Medical.Facility,Study,Histology,Grade,Age.at.diagnosis,Gender,Survival.Months,Survival.Status,Karnofsky.Performance.Score,Mutation.Count,Percent.Aneuploidy,IDH.Status,X1p.19q.Codeletion,IDH.Codel.Subtype,MGMT.Promoter.Status,Chr.7.gain.Chr.10.loss,Chr.19.20.co.gain,TERT.promoter.status,TERT.Expression,TERT.Expression.Status,ATRX.Status,DAXX.Status,BRAF.V600E.Status,BRAF.KIAA1549.Fusion,ABSOLUTE.Purity,ABSOLUTE.Ploidy,ESTIMATE.Stromal.Score,ESTIMATE.Immune.Score,ESTIMATE.Combined.Score,Original.Subtype,Transcriptome.Subtype,Pan.Glioma.RNA.Expression.Cluster,IDH.specific.RNA.Expression.Cluster,Pan.Glioma.DNA.Methylation.Cluster,IDH.specific.DNA.Methylation.Cluster,Supervised.DNA.Methylation.Cluster,Telomere.length.normal.sample,Telomere.length.tumor.sampleThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G2,31,female,4.6982507,0,90,15,0.069411737,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.79,2,422.0321,804.9614,1226.9936,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,8.1119,5.1859Thomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,67,male,7.6880466,1,90,50,0.224149226,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3.807354922,Expressed,WT,WT,WT,WT,0.61,2.05,706.8712,2283.2336,2990.1048,IDHwt,CL,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,1.4191,1.6129Thomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,44,female,43.8612915,1,90,24,0.093693446,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.76,2.05,563.4763,2076.2917,2639.768,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,37,male,18.1359048,0,50,30,0.172371054,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.83,3.92,460.2841,819.1347,1279.4188,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G2,50,male,10.6121327,0,90,20,0.060307007,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,0.74,1.94,701.1345,1281.992,1983.1265,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,3.2645,1.4981Thomas Jefferson University,Brain Lower Grade Glioma,oligodendroglioma,G2,47,female,64.5927334,0,100,32,0.051144394,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.247927513,Expressed,WT,WT,WT,WT,0.85,1.97,124.7414,-225.5518,-100.8105,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,39,male,40.1486878,0,100,26,0.057785896,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.53,4.15,521.7407,1277.3459,1799.0866,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,40,male,0.0985647,0,NA,22,0.046938447,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.92,1.95,-169.753,-301.6626,-471.4155,IDHmut-non-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,oligodendroglioma,G2,43,male,20.9942811,1,90,39,0.186123148,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,5.614709844,Expressed,WT,WT,WT,WT,0.81,2.05,471.8562,474.2103,946.0665,IDHwt,CL,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,6.678,16.669Thomas Jefferson University,Brain Lower Grade Glioma,oligodendroglioma,G3,53,female,9.9550347,0,90,26,0.179512208,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3,Expressed,WT,WT,WT,WT,0.89,1.97,490.2274,583.092,1073.3194,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,2.9974,1.6563Thomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,54,female,6.3738506,1,80,39,0.285381623,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,0.65,1.95,848.0038,1264.6034,2112.6072,IDHwt,NE,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,oligoastrocytoma,G3,58,male,17.6759362,1,90,56,0.151773246,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.087462841,Expressed,WT,WT,WT,WT,0.89,2.03,34.99213,866.84815,901.84028,IDHwt,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,3.711,1.7498Thomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,48,male,23.8198025,0,90,47,0.140632184,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3.906890596,Expressed,WT,WT,WT,WT,0.68,2.02,1044.685,1579.286,2623.971,IDHwt,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,31,male,17.9387754,0,90,15,0.013278287,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.54,4.02,1131.883,2597.619,3729.502,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,4.1844,3.8833Thomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,51,female,12.4191522,0,90,75,0.524813675,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.61,3.39,1786.503,2649.453,4435.957,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,4.9587,11.3163Thomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G3,22,male,8.4765642,0,90,18,0.403165128,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.24,4.49,1157.963,1091.053,2249.016,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,astrocytoma,G2,39,female,7.556627,0,90,23,0.066712803,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,NA,NA,737.1757,742.1025,1479.2782,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThomas Jefferson University,Brain Lower Grade Glioma,oligodendroglioma,G2,57,female,8.0165956,0,90,24,0.114883345,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.754887502,Expressed,WT,WT,WT,WT,0.98,1.95,-468.1921,-457.177,-925.3691,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,8.2067,5.0426Thomas Jefferson University,Brain Lower Grade Glioma,oligodendroglioma,G2,26,female,7.3923525,0,90,0,9.89E-06,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,NA,NA,-173.3958,-659.4781,-832.8739,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,7.2886,8.4559Thomas Jefferson University,Brain Lower Grade Glioma,oligodendroglioma,G3,43,male,6.6038349,0,NA,34,0.05993084,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.584962501,Expressed,WT,WT,WT,WT,0.82,1.95,128.6621,-322.693,-194.0309,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,38,female,97.8090373,0,NA,16,0.061381977,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.58,2.05,1054.4956,971.4132,2025.9087,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,33,male,81.9072657,0,NA,16,0.017349195,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.71,2.01,1279.42,1715.375,2994.795,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,6.266,4.4024Mayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,37,female,75.2048661,0,80,35,0.234427033,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.459431619,Expressed,WT,WT,WT,WT,0.82,1.95,1087.181,1216.976,2304.157,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,36,male,47.9024442,0,NA,29,0.206946718,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,1,5.69,209.0677,347.1534,556.2211,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,32,male,72.8721682,0,NA,11,0.00302201,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.36,2,1382.281,1698.966,3081.247,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,2.7011,6.3505Mayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,34,male,50.8265303,1,NA,37,0.821252896,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.9,1.81,376.6312,347.2356,723.8668,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G2,17,male,50.1365774,0,NA,7,0.051077676,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.78,1.95,483.30657,66.43313,549.7397,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,7.8519,5.3447Mayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G2,59,male,44.4855346,0,NA,44,0.945943231,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.321928095,Expressed,WT,WT,WT,WT,0.83,3.54,399.9002,393.4523,793.3525,IDHmut-codel,NE,LGr3,IDHmut-R2,LGm3,IDHmut-K3,Codel,2.7433,3.1208Mayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,43,male,36.5346488,0,NA,19,0.028538352,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1.584962501,Not expressed,Mutant,WT,WT,WT,0.88,1.97,493.5369,396.6311,890.168,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.0392,7.1049Mayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,61,male,78.2275169,0,NA,50,0.311681897,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.28,3.62,807.7703,382.4908,1190.2612,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,33,female,30.0622335,0,NA,23,0.095740577,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,NA,NA,-208.43019,90.42702,-118.00316,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,30,male,10.2835837,0,NA,8,0.1442725,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.584962501,Expressed,WT,WT,WT,WT,1,3.72,743.8234,967.3825,1711.2059,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,38,male,12.7148463,0,NA,33,0.051164527,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.9,1.96,-142.7558,378.5914,235.8356,IDHmut-non-codel,PN,LGr3,IDHmut-R2,LGm1,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,26,male,27.598116,0,NA,15,0.02248508,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,1,3.9,316.7981,1062.0402,1378.8384,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,32,male,27.0067278,0,NA,21,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,255.6404,132.2259,387.8663,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,27,female,18.8258577,0,90,21,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-31.29797,274.54469,243.24672,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,41,female,18.3658891,0,NA,20,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,567.8277,985.1064,1552.934,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G3,34,male,72.9050231,0,NA,21,NA,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.64385619,Expressed,WT,WT,WT,WT,0.92,1.91,-434.0275,-939.9305,-1373.958,IDHmut-codel,PN,LGr1,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,53,female,12.5834267,0,NA,34,NA,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,NA,NA,40.4471,-413.4674,-373.0203,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G2,67,female,11.0063915,0,70,58,0.245379721,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4,Expressed,WT,WT,WT,WT,0.61,3.82,-169.029,527.0226,357.9937,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,59,male,18.8258577,0,NA,18,0.204487967,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,2.321928095,Expressed,WT,WT,WT,WT,1,3.8,430.3288,940.2266,1370.5554,IDHwt,NE,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G3,40,male,16.7888539,0,NA,20,0.063460281,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.459431619,Expressed,WT,WT,WT,WT,0.87,1.91,701.5892,534.8716,1236.4608,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,31,female,5.9795918,0,90,19,0.088152361,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1.584962501,Not expressed,WT,WT,WT,WT,0.82,3.96,-264.182,-118.6993,-382.8812,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G2,24,female,16.0660461,0,90,12,0.051102987,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.044394119,Expressed,WT,WT,WT,WT,0.96,1.94,-265.1541,-551.9277,-817.0818,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,20,male,15.4089481,0,100,8,8.71E-06,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.87,1.95,1331.299,1789.046,3120.345,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G2,38,female,27.7952454,0,90,9,0.051764185,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.754887502,Expressed,WT,WT,WT,WT,0.78,1.95,338.75708,43.87827,382.63535,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligodendroglioma,G2,54,male,14.7189952,0,90,22,0.07717302,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1,Not expressed,WT,WT,WT,WT,1,3.83,1160.615,2078.352,3238.968,IDHmut-codel,NA,LGr3,IDHmut-R3,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,65,female,13.6347835,0,90,47,0.123656217,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.906890596,Expressed,WT,WT,WT,WT,0.8,3.8,-547.5549,-1122.4048,-1669.9597,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,56,female,10.9078268,0,90,60,0.08311908,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,98.9561,408.4276,507.3837,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,oligoastrocytoma,G3,55,female,7.3923525,0,NA,37,0.062290168,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.84,1.94,954.0238,1176.1848,2130.2086,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,36,female,6.4395604,0,90,37,0.11468665,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.71,3.98,530.7717,558.5025,1089.2742,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G2,47,male,10.2835837,0,NA,22,0.015790069,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,498.6716,973.5577,1472.2293,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G3,29,male,30.7193315,0,90,14,0.096711279,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,1,5.76,674.7015,1713.187,2387.8885,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Brain Lower Grade Glioma,astrocytoma,G2,25,female,3.8111684,0,NA,2,0.048291631,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,Mutant,WT,0.7,3.95,783.4472,1097.2674,1880.7146,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligoastrocytoma,G3,38,female,19.9429243,1,90,27,0.231272091,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.78,3.65,489.4716,454.6362,944.1078,IDHwt,PN,LGr1,IDHwt-R3,LGm6,IDHwt-K3,PA-like,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligodendroglioma,G3,32,male,31.8035432,0,NA,18,0.051579709,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.807354922,Expressed,WT,WT,WT,WT,0.79,1.95,616.4255,647.3855,1263.811,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Florida,Brain Lower Grade Glioma,astrocytoma,G3,29,male,30.2922178,0,90,23,0.112075218,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.77,3.85,1010.845,2582.811,3593.656,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligoastrocytoma,G3,30,male,14.3904462,0,80,23,1.63E-05,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.28,3.97,452.7031,976.9496,1429.6527,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,3.8841,1.3661University of Florida,Brain Lower Grade Glioma,oligodendroglioma,G3,56,female,8.0165956,0,100,28,0.05582584,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.426264755,Expressed,Mutant,WT,WT,WT,0.92,1.95,-212.6122,152.94377,-59.66842,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligodendroglioma,G3,70,male,30.1936531,1,NA,52,0.571285717,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,6.392317423,Expressed,WT,WT,WT,WT,0.77,5.71,253.9988,1099.79,1353.7889,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,4.1945,1.8981University of Florida,Brain Lower Grade Glioma,astrocytoma,G3,52,male,42.0214171,0,90,40,0.287854893,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,1,3.64,726.3444,2067.2022,2793.5466,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Brain Lower Grade Glioma,astrocytoma,G3,43,female,15.7374971,0,80,34,0.192947518,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.68,3.84,649.0929,1522.9235,2172.0164,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligodendroglioma,G2,49,male,17.1831127,0,90,15,0.051070531,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.857980995,Expressed,WT,WT,WT,WT,NA,NA,-8.131801,28.997996,20.866195,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligodendroglioma,G3,49,female,3.8440233,0,80,22,0.157254978,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.23,3.69,NA,NA,NA,IDHmut-non-codel,NA,NA,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligodendroglioma,G3,59,female,54.210585,0,90,51,0.096090229,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,0.59,3.9,252.0749,-146.426,105.6488,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Florida,Brain Lower Grade Glioma,oligodendroglioma,G2,50,male,10.2178739,0,NA,26,0.061169695,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.247927513,Expressed,WT,WT,WT,WT,0.74,1.9,280.9067,256.6927,537.5994,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAUniversity of Florida,Brain Lower Grade Glioma,astrocytoma,G3,30,male,6.57098,0,NA,16,0.204840295,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.69,2.04,483.1287,1081.2309,1564.3596,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAUniversity of Florida,Brain Lower Grade Glioma,astrocytoma,G3,43,male,3.4497645,0,90,40,0.116777692,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.75,3.85,212.3492,565.8944,778.2436,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Brain Lower Grade Glioma,astrocytoma,G3,49,male,6.2095761,0,90,30,0.080396345,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.56,3.95,442.3036,888.3832,1330.6869,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,34,female,18.0044852,0,NA,39,0.202337721,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.426264755,Expressed,WT,WT,WT,WT,0.76,1.79,813.7785,2410.5179,3224.2964,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,2.3717,4.6462Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,48,male,14.5547207,0,NA,27,0.104560727,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.392317423,Expressed,WT,WT,WT,WT,0.95,1.98,306.3579,289.4478,595.8057,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,4.3255,0.7282Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,40,female,17.4459519,0,90,26,0.064121426,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.44,1.93,438.923,508.3383,947.2613,IDHmut-non-codel,NA,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,61,female,6.7352545,1,80,78,0.161024593,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.044394119,Expressed,Mutant,WT,WT,WT,0.82,1.91,1437.562,1781.327,3218.889,IDHwt,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,4.0524,0.4822Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,29,male,13.3719443,0,100,14,0.097621782,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.83,2,874.4025,1660.4838,2534.8862,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,57,female,8.4437093,0,90,47,0.165181706,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3.700439718,Expressed,WT,WT,WT,WT,0.52,2.02,1674.433,1950.452,3624.885,IDHwt,CL,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,3.6419,1.059Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,49,female,6.8009643,0,100,49,0.101937655,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.56,1.97,666.8654,1536.2764,2203.1418,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,34,female,182.2132754,0,70,16,0.125972025,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.807354922,Expressed,WT,WT,WT,WT,0.81,1.96,733.32,581.7531,1315.0731,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,5.5833,2.1886Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,37,female,18.9244224,0,100,25,0.185353191,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.9,2.07,268.329,1179.802,1448.131,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,43,female,17.4788068,0,NA,30,0.045576569,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.82,1.95,1020.475,1558.812,2579.287,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,4.5276,5.9032Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,62,female,15.1461089,0,100,40,0.066341965,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.459431619,Expressed,WT,WT,WT,WT,0.96,1.93,-36.71883,-318.53327,-355.2521,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,6.2307,12.532Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,35,female,211.0270227,0,NA,12255,0.146773116,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,Mutant,WT,WT,0.78,2.07,1297.609,1336.608,2634.216,IDHwt,PN,LGr1,IDHwt-R3,LGm6,IDHwt-K3,PA-like,4.724,29.2683Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,66,male,52.0750165,1,NA,29,0.163412101,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,6,Expressed,WT,WT,WT,WT,0.96,1.95,-152.7153,-407.0734,-559.7887,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,53,male,22.4070418,1,NA,30,0.051322041,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.98,1.95,31.02553,349.23604,380.26157,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,31,male,48.9866559,1,NA,25,0.095827341,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.89,2.06,525.7137,757.4074,1283.1211,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,31,female,75.1063014,1,90,42,0.16834851,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.63,3.85,1430.267,2904.157,4334.423,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,45,male,46.0297149,1,NA,20,0.14039477,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.169925001,Expressed,WT,WT,WT,WT,0.78,1.94,613.9526,567.2547,1181.2073,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,4.9616,3.3614Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,54,male,65.7098,1,NA,42,0.144615258,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.73,4,969.4754,1378.3691,2347.8445,IDHwt,PN,LGr3,IDHwt-R3,LGm2,IDHmut-K2,G-CIMP-high,5.0474,5.4398Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,66,female,1.2156313,1,NA,46,0.293727337,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.700439718,Expressed,WT,WT,WT,WT,0.91,1.91,-301.66382,25.32643,-276.33739,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,31,female,87.394034,1,NA,21,0.165351565,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,1296.74,1040.825,2337.565,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,8.6892,14.5523Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,52,male,7.0309486,1,NA,45,0.157723154,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.584962501,Expressed,WT,WT,WT,WT,0.64,1.97,1302.147,2291.561,3593.708,IDHwt,CL,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,4.8431,2.093Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,60,female,11.6306346,1,90,58,0.122333932,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,5.129283017,Expressed,WT,WT,WT,WT,0.71,2,396.5508,1599.2802,1995.8309,IDHwt,PN,LGr1,IDHwt-R3,LGm5,IDHwt-K1,Classic-like,5.0039,1.7225Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,24,female,133.6537332,1,100,11,0.117890848,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.27,2.13,893.0725,732.5777,1625.6502,IDHwt,CL,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,5.9552,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,51,female,19.8772145,1,90,58,0.137197864,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,5.700439718,Expressed,WT,WT,WT,WT,0.88,1.93,-4.816645,1367.577293,1362.760648,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,4.9394,1.7927Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,59,female,16.8217088,1,NA,3,0.146686205,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,6.321928095,Expressed,WT,WT,WT,WT,0.98,2.05,512.3709,1454.4238,1966.7948,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,35,female,94.4578375,1,90,21,0.274907624,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1.584962501,Not expressed,Mutant,WT,WT,WT,0.8,2.08,416.4771,505.6738,922.1509,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,7.8905,12.158Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,23,female,114.006503,1,90,19,0.160242254,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.85,1.99,252.1355,1016.1369,1268.2724,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,5.1395,12.4753Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,56,male,7.9508858,0,50,36,0.165761568,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.857980995,Expressed,WT,WT,WT,WT,0.97,1.94,-326.5518,-990.9741,-1317.5259,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,25,male,7.7209015,0,NA,23,0.154079856,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.82,1.94,907.9316,1494.3408,2402.2724,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.6833,14.2681Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,60,female,11.4663601,1,NA,52,0.208149912,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3,Expressed,WT,WT,WT,WT,0.73,1.9,1124.054,2427.774,3551.828,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,4.7249,3.9526Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G2,33,male,62.9171335,1,NA,40,0.346159536,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.84,2.1,1531.026,2088.04,3619.066,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.7253,22.8888Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,41,female,156.1264848,0,NA,26,0.107814398,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.82,2.05,-342.36833,-19.81471,-362.18305,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,6.4557,6.1162Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,32,female,138.1877094,0,NA,14,0.092996777,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.321928095,Expressed,WT,WT,WT,WT,NA,NA,-163.8836,-516.0634,-679.947,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,10.6402,6.0016Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,58,female,14.9818344,1,NA,83,0.635907935,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.75,3.86,623.7099,661.1522,1284.8621,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,5.484,10.3677Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,25,male,105.13568,1,80,13,0.000335566,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,1915.603,1882.338,3797.941,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,74,female,6.5381251,1,NA,62,0.199718345,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,0.53,1.92,2016.715,3187.245,5203.959,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,59,male,8.8379681,1,80,40,0.212238798,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,6.022367813,Expressed,WT,WT,WT,WT,0.96,2.18,323.6763,1320.6832,1644.3595,IDHwt,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,4.6005,4.6692Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,59,male,117.3248479,1,100,NA,0.197249797,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,NA,NA,NA,WT,0.77,2.07,676.2054,971.7021,1647.9075,NA,PN,LGr3,NA,LGm2,NA,NA,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,41,female,90.7123789,0,90,19,0.141449197,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.33,4.24,590.2606,1864.3107,2454.5713,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,57,female,30.6536217,1,90,28,0.167952524,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,6.392317423,Expressed,WT,WT,WT,WT,0.87,3.85,47.67645,-421.29328,-373.61682,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,4.4932,2.5294Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,39,male,26.28392,0,100,28,0.049749911,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.74,2,1089.417,1110.414,2199.831,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,45,female,10.3492935,1,NA,35,0.200587829,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.68,1.95,1026.511,2448.837,3475.347,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,6.2068,2.0732Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,69,male,7.9508858,1,NA,46,0.121583533,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.66,2.01,363.9579,261.9846,625.9425,IDHwt,NE,LGr2,IDHwt-R4,LGm4,IDHwt-K1,Classic-like,3.8837,1.0503Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,53,female,94.2607081,0,100,54,0.115885826,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.906890596,Expressed,WT,WT,WT,WT,0.93,1.88,86.04189,-133.62765,-47.58576,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,5.9201,1.6178Henry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,38,female,18.9244224,1,80,41,0.200874945,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.76,1.91,176.7983,752.4009,929.1991,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,33,male,43.9927111,1,90,23,0.075350198,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.68,3.95,297.0707,1050.7089,1347.7797,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,53,female,61.9643414,1,90,51,0.080147627,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.321928095,Expressed,WT,WT,WT,WT,0.67,1.92,621.7164,582.6123,1204.3287,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,53,male,25.8896612,1,100,22,0.113304684,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,3.584962501,Expressed,Mutant,WT,WT,WT,0.88,1.98,1184.69,1647.323,2832.013,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.9569,9.3394Henry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,48,female,60.2558866,0,90,24,0.135109975,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.169925001,Expressed,WT,WT,WT,WT,0.89,1.88,-309.8857,-339.5195,-649.4052,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,43,male,23.2941241,1,80,23,0.229171051,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.8,2.1,759.0484,1250.2464,2009.2949,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,4.5594,7.1714Henry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,67,male,41.9557073,0,100,50,0.103648078,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.85,2.09,767.1202,1077.2725,1844.3927,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,41,female,2.7598116,0,90,28,0.070012526,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1.584962501,Not expressed,Mutant,WT,WT,WT,NA,NA,747.6695,426.1658,1173.8353,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,57,female,5.0925095,1,80,37,0.41489159,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.7,1.69,1194.949,2248.671,3443.62,IDHwt,NA,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,63,female,23.7212378,1,70,45,0.263951081,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,1,Not expressed,WT,WT,WT,WT,0.54,1.89,1230.677,2486.871,3717.547,IDHwt,CL,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,61,female,14.5875756,1,80,17,0.009521402,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.2,2.17,578.332,343.8386,922.1706,IDHwt,NE,LGr2,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,29,male,20.6657321,0,90,12,0.054421461,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.46,4.11,885.7573,1561.645,2447.4023,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,51,male,21.3885399,0,NA,24,0.05274221,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.087462841,Expressed,WT,WT,WT,WT,0.91,1.95,-246.7828,-557.9299,-804.7128,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,60,female,19.1215518,0,90,60,0.498608812,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3.321928095,Expressed,WT,WT,WT,WT,0.58,5.76,1237.653,2047.679,3285.332,IDHwt,NA,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,29,female,16.9531284,0,NA,18,0.086435503,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.84,2.04,234.5803,695.3936,929.9739,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,69,female,15.4746579,0,100,39,0.183695412,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.44,3.87,1207.281,1544.623,2751.904,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,55,female,14.1604619,0,70,58,0.185805222,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.906890596,Expressed,WT,WT,WT,WT,1,1.91,-448.2007,-361.3952,-809.5958,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,33,male,14.2261717,0,70,24,0.026880922,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.7,3.85,764.5119,2588.4199,3352.9318,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,51,male,12.5834267,0,90,34,0.098120223,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.72,1.98,1416.786,3215.458,4632.244,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,42,male,15.113254,0,100,41,0.215247227,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.78,1.95,356.5518,853.2791,1209.831,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,70,male,4.9610899,0,NA,52,0.270027306,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.584962501,Expressed,WT,WT,WT,WT,0.47,4.65,564.2519,926.1628,1490.4147,IDHwt,NA,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G2,62,female,3.6468939,0,50,35,0.225325218,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.81,2.04,909.7726,2042.6201,2952.3927,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm3,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,33,female,5.6510428,0,100,37,0.138419013,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.57,4.34,-8.395784,181.224007,172.828223,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,46,female,12.1891679,0,NA,48,0.243985673,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.392317423,Expressed,WT,WT,WT,WT,0.56,4.11,1405.526,2732.079,4137.605,IDHwt,CL,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,37,female,8.6408387,0,70,16,0.051743821,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.807354922,Expressed,WT,WT,WT,WT,0.54,3.9,86.6681,-338.0319,-251.3638,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,60,male,2.6941018,0,NA,32,0.116043461,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,1,1.9,-59.23056,-549.93829,-609.16885,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G2,35,female,77.9318228,0,90,14,0.124344838,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.392317423,Expressed,WT,WT,WT,WT,0.89,1.97,-142.103,-769.2612,-911.3642,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,27,female,7.228078,0,90,20,0.144639486,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.76,4.06,500.7665,958.2866,1459.0531,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,74,female,5.9795918,0,90,53,0.798688381,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.614709844,Expressed,WT,WT,WT,WT,0.78,3.66,-141.4535,-180.917,-322.3705,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,87,male,11.4006503,1,NA,46,0.217007761,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,3.906890596,Expressed,WT,WT,WT,WT,0.61,1.94,107.1767,-281.064,-173.8874,IDHwt,NE,LGr4,IDHwt-R4,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,54,male,26.7438886,1,NA,40,0.162556867,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4,Expressed,WT,WT,WT,WT,0.64,1.93,2249.248,2065.702,4314.949,IDHwt,ME,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G2,30,male,7.1295133,0,NA,18,0.090321929,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.71,3.98,600.2818,1865.0952,2465.377,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,51,male,21.2899752,1,50,41,0.424752984,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.82,1.89,365.2485,140.9946,506.243,IDHmut-codel,NE,LGr3,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G3,73,female,17.9716303,1,60,98,0.24976636,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4,Expressed,WT,WT,WT,WT,0.86,5.54,717.36906,53.46586,770.83492,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,35,male,124.4215063,0,100,14,0.140785716,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.78,4.02,1139.194,1318.421,2457.615,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,32,male,77.8332581,0,80,36,0.325515813,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.75,3.84,784.5827,1323.236,2107.8187,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,56,male,42.2842563,0,100,33,0.038380938,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3,Expressed,WT,WT,WT,WT,0.68,1.96,334.61925,67.18217,401.80142,IDHwt,PN,LGr1,IDHwt-R3,LGm6,IDHwt-K3,PA-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G2,32,male,23.4912535,0,90,24,0.119565542,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.64,3.83,-126.73594,-12.96649,-139.70243,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligoastrocytoma,G3,52,male,7.4909172,1,60,46,0.154101463,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.700439718,Expressed,WT,WT,WT,WT,0.81,1.96,1177.879,2312.366,3490.245,IDHwt,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,oligodendroglioma,G2,40,male,44.3869699,1,70,8,0.010258559,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.48,3.83,556.4093,383.9807,940.39,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm1,IDHmut-K1,G-CIMP-high,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,NA,0.066014053,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,NA,NA,NA,WT,0.73,3.96,555.9128,1326.2779,1882.1906,NA,NE,LGr3,NA,LGm2,NA,NA,NA,NAHenry Ford Hospital,Brain Lower Grade Glioma,astrocytoma,G3,55,male,0.5585333,0,NA,40,0.175996709,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,6.523561956,Expressed,WT,WT,WT,WT,0.87,1.93,519.8359,1429.6179,1949.4538,IDHwt,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Brain Lower Grade Glioma,astrocytoma,G3,41,male,50.1037225,1,100,20,0.186385129,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.83,2.02,675.8791,1590.1201,2265.9991,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,astrocytoma,G3,38,male,67.4182548,1,80,28,0.092286768,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.48,4.08,1116.207,2094.621,3210.828,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.2593,6.2238Duke,Brain Lower Grade Glioma,astrocytoma,G3,42,male,41.1014799,1,90,30,0.656226846,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.95,3.46,-617.8775,-291.8108,-909.6883,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NADuke,Brain Lower Grade Glioma,astrocytoma,G3,34,male,79.9359717,1,100,23,0.158418253,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.77,1.95,445.0893,709.3338,1154.4231,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,5.2519,4.7248Duke,Brain Lower Grade Glioma,astrocytoma,G3,62,female,57.8903338,1,80,57,0.170623284,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.23,3.79,-64.83463,616.41668,551.58206,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm3,IDHmut-K2,G-CIMP-high,4.9204,4.9876Duke,Brain Lower Grade Glioma,oligodendroglioma,G3,31,male,134.1794116,1,100,15,0.190924835,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.169925001,Expressed,WT,WT,WT,WT,0.85,1.92,-44.17632,-359.79667,-403.97299,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NADuke,Brain Lower Grade Glioma,oligodendroglioma,G2,42,female,78.1618071,1,100,26,0.071555237,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.044394119,Expressed,WT,WT,WT,WT,0.82,3.92,634.8084,407.757,1042.5654,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,7.5407,6.2087Duke,Brain Lower Grade Glioma,oligodendroglioma,G2,48,female,95.5091943,1,100,34,0.060609253,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.459431619,Expressed,WT,WT,WT,WT,0.7,1.94,802.7531,734.0053,1536.7584,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,7.5188,4.6651Duke,Brain Lower Grade Glioma,oligoastrocytoma,G2,38,female,130.6967922,1,90,22,0.155850991,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,Mutant,WT,WT,WT,0.74,3.87,491.2776,1626.405,2117.6826,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,59,0.557405362,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.882643049,Expressed,WT,WT,WT,WT,0.79,3.28,-2.643479,810.209671,807.566193,IDHwt,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,71,0.211787788,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.8,1.9,1647.228,2003.921,3651.148,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,22,0.026134886,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.54,4,235.1809,869.5521,1104.733,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,40,0.172742641,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.92,2,147.1196,470.6161,617.7357,IDHmut-non-codel,PN,LGr1,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,45,0.161861176,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,5.584962501,Expressed,WT,WT,WT,WT,0.78,1.91,664.3721,2017.1512,2681.5233,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,35,0.127001877,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.42,5.55,1424.084,2595.555,4019.639,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,58,0.224175989,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,5.523561956,Expressed,WT,WT,WT,WT,0.53,3.83,1233.011,2202.785,3435.796,IDHwt,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,49,0.160078039,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.5,1.9,161.6956,607.8392,769.5348,IDHwt,NE,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,58,0.148040382,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.37,2.07,2159.292,3641.506,5800.798,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Brain Lower Grade Glioma,oligodendroglioma,G3,45,male,74.9748818,1,100,28,0.051081999,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.76,3.8,120.1803,-234.0275,-113.8472,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,30,0.680271039,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.906890596,Expressed,WT,WT,WT,WT,0.59,2.94,1840.308,2809.679,4649.987,IDHwt,ME,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,52,0.935998526,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.584962501,Expressed,WT,WT,WT,WT,NA,NA,-615.6462,-524.3587,-1140.0049,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,25,0.040411492,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.58,3.96,308.6161,328.7814,637.3975,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,oligoastrocytoma,G3,26,female,32.4277863,1,90,43,0.316144333,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.75,3.84,170.55046,-98.68743,71.86303,IDHmut-non-codel,PN,LGr1,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NADuke,Brain Lower Grade Glioma,oligoastrocytoma,G2,28,male,36.797488,1,90,21,0.06234041,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.59,3.98,406.4722,723.4222,1129.8944,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,2,9.73E-05,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.321928095,Expressed,WT,WT,WT,WT,0.44,2.05,239.6527,132.6699,372.3226,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm1,IDHmut-K1,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,36,0.194998589,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,0.74,1.97,-79.615739,-2.825361,-82.441099,IDHwt,NE,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,19,0.02428067,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.5,4.11,912.4161,755.885,1668.301,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,14,0.094743361,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.7,3.76,10.0053,1405.6375,1415.6428,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Brain Lower Grade Glioma,astrocytoma,G2,41,female,32.3292216,1,90,18,0.025972375,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.63,4.07,167.7101,679.2945,847.0045,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUNC,Brain Lower Grade Glioma,oligodendroglioma,G2,47,female,14.3247364,0,NA,26,0.216241234,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.321928095,Expressed,WT,WT,WT,WT,NA,NA,-262.2033,-568.6329,-830.8362,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,5.6811,3.9472Asterand,Brain Lower Grade Glioma,oligodendroglioma,G2,34,male,0.2299843,0,NA,26,0.116113083,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.554588852,Expressed,WT,WT,WT,WT,NA,NA,-478.5512,-453.8549,-932.4061,IDHmut-codel,NA,LGr1,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAAsterand,Brain Lower Grade Glioma,astrocytoma,G2,44,male,0.1971294,0,NA,27,0.116101742,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-242.5626,-255.0452,-497.6077,IDHmut-non-codel,NA,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G3,54,male,47.7381697,0,NA,22,0.515323259,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.321928095,Expressed,WT,WT,WT,WT,0.83,1.91,153.49352,-26.55734,126.93618,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G3,23,male,25.4625475,1,90,21,0.517422121,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.42,1.76,1598.292,2527.345,4125.638,IDHwt,ME,LGr3,IDHwt-R3,LGm6,IDHwt-K3,PA-like,4.1177,17.723Case Western,Brain Lower Grade Glioma,oligodendroglioma,G2,62,male,34.3333705,0,NA,29,0.175968796,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.700439718,Expressed,WT,WT,WT,WT,0.64,1.85,598.0968,1503.6899,2101.7867,IDHmut-codel,PN,LGr3,IDHmut-R2,LGm3,IDHmut-K3,Codel,6.6483,2.7294Case Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,39,female,36.797488,1,90,41,0.152515243,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.58,3.95,623.6008,1171.6313,1795.2322,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,4.8603,6.8852Case Western,Brain Lower Grade Glioma,astrocytoma,G3,59,female,18.7601479,0,80,60,0.137086653,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,1.584962501,Not expressed,WT,WT,WT,WT,0.38,1.99,949.5884,2061.5289,3011.1173,IDHwt,NA,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,4.0427,NACase Western,Brain Lower Grade Glioma,astrocytoma,G2,30,male,14.9161246,0,70,13,0.064967003,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.59,1.93,400.6346,1146.3396,1546.9742,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.5788,10.7412Case Western,Brain Lower Grade Glioma,oligodendroglioma,G2,70,male,24.969724,0,90,17,0.041886615,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.53,2.02,480.8889,1174.7977,1655.6867,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.7343,7.4008Case Western,Brain Lower Grade Glioma,astrocytoma,G2,23,female,23.9512221,0,100,8,0.09317283,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.82,2.1,979.8921,1869.0095,2848.9016,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.4884,7.9554Case Western,Brain Lower Grade Glioma,oligodendroglioma,G3,63,male,18.4315989,1,NA,86,0.142016101,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,5.832890014,Expressed,WT,WT,WT,WT,0.84,2,698.3993,1649.1059,2347.5052,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,6.6047,4.2922Case Western,Brain Lower Grade Glioma,oligodendroglioma,G2,28,male,15.3432383,0,NA,15,0.335227523,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.459431619,Expressed,WT,WT,WT,WT,NA,NA,1645.409,1481.083,3126.492,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G3,48,male,17.8730656,0,90,34,0.118608363,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.81,3.94,7.638575,584.568792,592.207367,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.3617,12.4102Case Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,49,male,40.0501231,0,NA,25,0.086050656,Mutant,non-codel,IDHmut-non-codel,Methylated,NA,NA,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,452.7485,190.5136,643.262,IDHmut-non-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G3,31,female,22.5384614,0,100,17,0.051242594,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.584962501,Expressed,Mutant,WT,WT,WT,0.88,1.95,365.7822,255.0907,620.8729,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,31,male,20.6000223,0,NA,19,0.084861034,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.700439718,Expressed,WT,WT,WT,WT,0.79,1.91,-361.225,-880.6704,-1241.8954,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,49,female,20.0743439,0,NA,30,0.150950432,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.28,1.99,669.6386,381.8585,1051.4971,IDHwt,NE,LGr2,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,4.4265,4.009Case Western,Brain Lower Grade Glioma,oligoastrocytoma,G3,23,male,12.9448306,0,90,0,6.98E-06,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,511.1936,-22.24667,488.94692,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,35,male,13.6676384,0,NA,19,0.019481437,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.2,2.11,571.067,1006.603,1577.67,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,8.7083,2.9339Case Western,Brain Lower Grade Glioma,astrocytoma,G3,37,male,14.2261717,0,90,31,0.094821225,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.87,2.01,118.1838,372.07,490.2538,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G3,42,female,16.0003363,0,70,20,0.074928694,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1.584962501,Not expressed,WT,WT,WT,WT,0.82,1.99,395.3179,1440.1442,1835.4621,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,31,male,20.0743439,0,90,9,0.051142256,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.807354922,Expressed,WT,WT,WT,WT,0.73,1.95,382.563,472.1436,854.7066,IDHmut-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,41,male,14.9489795,0,90,27,0.060252057,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.28,3.96,653.9824,797.9442,1451.9265,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,33,female,11.8606189,0,70,0,6.08E-06,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,-101.5824,-808.3228,-909.9052,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm6,IDHmut-K1,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G3,30,male,15.5075128,0,NA,19,0.019876338,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.42,3.96,841.4705,1105.2925,1946.763,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,27,female,38.2431036,0,100,19,0.09769253,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.87,3.9,103.2279,205.7718,308.9997,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.072,5.1528Case Western,Brain Lower Grade Glioma,oligoastrocytoma,G3,58,male,0.5913882,0,NA,71,0.147986975,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,6.442943496,Expressed,WT,WT,WT,WT,0.91,2.04,1518.709,2168.586,3687.296,IDHwt,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G3,63,male,5.256784,0,80,85,0.168027552,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.321928095,Expressed,WT,WT,WT,WT,0.72,1.94,701.092,781.9924,1483.0844,IDHwt,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G2,47,male,18.6944381,0,100,17,0.033809253,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,162.0484,546.6845,708.7329,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,44,female,9.6593406,0,NA,22,0.22501935,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.93,3.96,405.9795,729.0456,1135.025,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,47,female,7.0309486,0,90,33,0.053945413,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.392317423,Expressed,WT,WT,WT,WT,0.75,3.93,499.3426,834.0718,1333.4143,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,34,female,6.6366898,0,NA,18,0.051601311,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.754887502,Expressed,WT,WT,WT,WT,0.83,3.9,-37.48372,305.09927,267.61555,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G2,34,female,7.0309486,0,100,22,0.107994241,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.76,4.02,750.1072,1750.7504,2500.8576,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,60,male,4.2054272,0,NA,43,0.15028742,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6.50779464,Expressed,WT,WT,WT,WT,0.96,1.86,-26.10569,506.08798,479.98228,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,44,female,4.0740076,0,70,17,0.116968339,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.754887502,Expressed,WT,WT,WT,WT,NA,NA,498.0626,925.3134,1423.376,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G3,52,female,10.5792778,0,90,68,0.505741665,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.7,3.77,1599.891,2646.258,4246.149,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,20,female,28.5180532,0,NA,15,0.053308179,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,1,4.11,816.9543,1231.0532,2048.0075,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G3,53,female,10.7764072,0,NA,60,0.143534597,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2.584962501,Expressed,WT,WT,WT,WT,0.7,1.97,1499.718,1682.66,3182.377,IDHwt,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,50,female,22.9327202,0,NA,23,0.051734004,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.83,1.95,840.8401,1700.1486,2540.9888,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,oligodendroglioma,G2,33,female,43.6641621,0,90,35,0.062512465,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.74,2,-288.80869,343.23397,54.42529,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western,Brain Lower Grade Glioma,oligoastrocytoma,G2,74,female,5.2239291,0,60,23,0.069264551,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.29,3.87,409.78482,-342.57884,67.20597,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G3,37,female,7.4252074,0,NA,30,0.072818582,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,NA,NA,-111.5443,396.8329,285.2885,IDHmut-non-codel,NA,LGr1,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NACase Western,Brain Lower Grade Glioma,astrocytoma,G3,61,female,5.7167526,0,80,64,0.196470908,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3,Expressed,WT,WT,WT,WT,NA,NA,1403.227,2365.591,3768.818,IDHwt,NA,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NAInternational Genomics Consortium,Brain Lower Grade Glioma,oligoastrocytoma,G3,25,male,0.1314196,0,NA,19,0.021220731,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.91,1.98,1300.784,2460.478,3761.262,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,6.3253,19.2986Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,54,male,0.0985647,0,NA,24,0.051687749,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.807354922,Expressed,WT,WT,WT,WT,0.22,3.82,478.7385,112.1833,590.9217,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,30,male,6.6695447,0,80,15,0.1004457,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.321928095,Expressed,WT,WT,WT,WT,0.99,1.92,168.1035,299.9256,468.0291,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,5.4533,2.5218Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,30,male,11.5320699,1,NA,35,0.615851639,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.95,3.69,204.1482,562.8332,766.9814,IDHwt,CL,LGr4,IDHwt-R3,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,37,male,8.8051132,0,90,37,0.096925407,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.79,3.96,463.5714,402.4469,866.0183,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,37,female,0.1314196,0,NA,16,0.293039192,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5,Expressed,WT,WT,WT,WT,0.94,1.95,879.8094,1423.054,2302.8635,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,38,male,0.0328549,0,NA,20,0.021373522,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.71,1.98,842.8085,1532.8506,2375.6591,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.6305,11.9708Case Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,28,male,16.5260147,0,NA,16,0.14666407,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.77,2.1,957.4817,2469.5097,3426.9914,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,3.3161,4.3576Case Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,52,male,3.7454586,0,NA,20,0.063653869,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.61,2.01,285.1207,150.3393,435.4601,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,67,male,17.413097,0,70,47,0.184557275,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.84,2.03,-391.349,-257.8883,-649.2373,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,3.126,6.3539Case Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,26,male,6.5381251,0,NA,18,0.212684814,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.71,2.03,1303.2447,722.6116,2025.8563,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,4.0291,5.229Case Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,62,male,24.2469162,0,80,48,0.681390542,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,1,3.59,396.8349,631.201,1028.0359,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,36,male,6.3738506,0,NA,23,0.086454705,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.64,1.97,1527.128,2590.05,4117.178,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,44,male,7.0966584,0,NA,19,0.065196266,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.52,2.07,1120.011,1474.606,2594.617,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,33,male,75.1391563,0,NA,23,0.078841925,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.95419631,Expressed,WT,WT,WT,WT,0.89,1.95,8.414446,-176.71863,-168.304185,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,39,male,59.13882,0,NA,19,0.051685647,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.700439718,Expressed,WT,WT,WT,WT,0.58,1.95,107.1709,-148.2192,-41.0483,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,2.8391,3.3896Case Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,18,female,59.9930474,0,NA,17,0.111670625,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.65,2.02,821.6346,1371.5554,2193.1899,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,14,male,154.089481,0,NA,11,0.042597054,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.81,2.01,897.2586,469.1837,1366.4423,IDHmut-non-codel,PN,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,42,male,4.0082978,0,100,12,0.013419587,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.8,1.99,161.436,859.3837,1020.8196,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,30,female,5.0267997,0,NA,19,0.045283081,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.65,2,1737.809,2701.696,4439.505,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,5.5645,13.9573Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,21,male,29.8322492,0,NA,3,0.000677618,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.47,2,630.2686,1041.5475,1671.816,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K1,G-CIMP-high,9.8736,2.5206Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,29,male,23.1627045,0,NA,25,0.038147897,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.59,1.98,-89.50003,-312.93784,-402.43787,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,50,male,107.8626367,0,NA,39,0.081549376,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.9,2.1,92.40893,352.72325,445.13219,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,4.8081,10.9635Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,38,male,4.5668311,0,NA,22,0.051674959,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1,Not expressed,WT,WT,WT,WT,0.68,1.95,276.6476,20.14954,296.79714,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,30,female,17.2816774,0,NA,32,0.285139555,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.95,1.87,152.8247,350.0036,502.8283,IDHmut-non-codel,PN,LGr1,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,61,female,3.1540704,1,70,25,0.084382454,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2,Expressed,WT,WT,WT,WT,0.36,1.96,437.3468,389.5658,826.9125,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,61,male,22.0456379,0,NA,16,0.051573926,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,0.85,1.95,615.0038,782.5646,1397.5684,IDHmut-codel,NE,LGr3,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,34,male,45.9640051,0,90,18,0.076216624,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.16,1.97,405.4751,1124.2874,1529.7625,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,25,female,56.0504594,0,NA,14,0.040327137,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.63,2.03,139.9169,-289.2028,-149.2858,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,36,male,57.5617848,0,90,24,0.049030322,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.63,3.83,575.9547,1274.5048,1850.4595,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,75,male,0.2299843,1,NA,37,0.141555587,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1,Not expressed,WT,WT,WT,WT,0.79,1.89,1470.032,2183.427,3653.459,IDHmut-codel,ME,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,40,male,14.2590266,0,NA,19,0.054353679,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2,Expressed,WT,WT,WT,WT,0.42,1.94,239.3377,649.3089,888.6467,IDHmut-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,26,male,0.1642745,0,NA,17,0.025472974,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.71,3.94,624.3962,1603.3123,2227.7085,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,53,male,16.2303206,0,NA,23,0.069098926,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.044394119,Expressed,WT,WT,WT,WT,0.77,3.91,332.25343,-20.71971,311.53373,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,32,female,0.7556627,0,NA,3,4.78E-05,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,749.0712,1913.2769,2662.3481,IDHwt,NA,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,29,female,44.6498091,0,NA,13,0.06121353,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2,Expressed,WT,WT,WT,WT,0.73,1.95,460.0274,592.9314,1052.9588,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,58,male,6.0453016,0,NA,29,0.046140657,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.169925001,Expressed,WT,WT,WT,WT,0.62,2.05,894.741,1478.809,2373.55,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,29,female,42.71137,0,NA,16,0.111740994,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.55,3.96,1081.958,2512.864,3594.822,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,74,male,0.0985647,0,NA,31,0.051678318,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2,Expressed,WT,WT,WT,WT,0.84,1.95,436.141,472.3568,908.4978,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,59,male,31.6721236,0,NA,44,0.332887683,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.53,3.81,-78.46741,-268.83278,-347.30018,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,58,female,14.9489795,0,60,42,0.206937714,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.72,1.91,352.431,793.4237,1145.8547,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,5.75,14.8776Case Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,29,male,0.0985647,0,NA,19,0.113557504,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.79,1.88,1429.272,1905.953,3335.225,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,31,female,0.0985647,0,NA,7,0.000794934,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,Fusion,NA,NA,1303.852,1856.876,3160.728,IDHwt,NA,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,43,male,2.956941,0,100,20,0.813885049,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.906890596,Expressed,WT,WT,WT,WT,0.91,1.92,-54.3314,235.8677,181.5363,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,51,female,17.5116617,0,90,26,0.095301714,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.93,2.04,692.489,1614.698,2307.187,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,60,male,6.899529,0,90,26,0.051718379,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1.584962501,Not expressed,WT,WT,WT,WT,0.46,1.95,-63.21741,-502.05053,-565.26794,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,29,female,14.5218658,0,NA,18,0.051031853,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.584962501,Expressed,WT,WT,WT,WT,0.77,1.95,89.47008,-354.54413,-265.07405,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,7.2014,6.4153Case Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,62,male,39.4587349,0,100,26,0.000443653,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,1.584962501,Not expressed,WT,WT,WT,WT,0.63,2,971.3481,1901.0134,2872.3615,IDHwt,NE,LGr4,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,39,male,19.2201165,0,NA,32,0.114856682,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,NA,NA,207.5211,610.9844,818.5055,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,35,male,39.0644761,0,NA,8,0.131429491,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.807354922,Expressed,WT,WT,WT,WT,0.35,3.74,262.92641,-290.88735,-27.96094,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,24,female,0.2299843,0,NA,19,0.081956696,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.4,3.82,3004.773,3710.553,6715.326,IDHwt,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,28,male,50.596546,0,NA,13,0.016324723,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.6,1.9,923.1892,1845.0218,2768.211,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,60,female,0.4928235,0,NA,80,0.171275527,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,4.247927513,Expressed,WT,WT,WT,WT,0.74,2.04,742.5621,1934.6651,2677.2272,IDHwt,CL,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,29,male,23.5898182,0,NA,27,0.121010881,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,426.2906,438.7323,865.0229,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,41,female,37.126037,0,NA,15,0.051563186,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.43,1.94,210.7548,-345.2897,-134.5348,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,56,male,0.328549,0,80,27,0.056738938,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.321928095,Expressed,WT,WT,WT,WT,0.84,3.79,-16.51269,-480.05204,-496.56473,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,20,female,0.1314196,0,NA,11,0.051028281,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.169925001,Expressed,WT,WT,WT,WT,0.66,1.94,199.99082,-257.38224,-57.39142,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,31,male,3.6797488,0,NA,14,0.09092968,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.66,3.88,789.6925,831.4096,1621.102,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,30,male,5.3224938,0,NA,5,5.52E-06,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,1,3.9,444.5849,189.4815,634.0664,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,38,male,2.9240861,0,NA,7,0.062554565,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.321928095,Expressed,WT,WT,WT,WT,0.43,1.85,-98.47013,-575.48752,-673.95765,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,66,male,3.7126037,1,NA,37,0.143116155,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.321928095,Expressed,WT,WT,WT,WT,NA,NA,3945.004,3681.788,7626.793,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,44,female,11.2692307,0,80,25,0.077589273,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.62,3.95,156.13167,-224.32183,-68.19016,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,30,female,31.4092844,0,NA,13,0.061109954,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.18,3.65,322.2553,519.9876,842.2428,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,64,female,1.642745,0,NA,12,0.061200044,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.43,3.88,506.6151,486.4989,993.1139,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,55,male,16.2303206,0,NA,48,0.182032112,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,6.303780748,Expressed,WT,WT,WT,WT,0.85,2.07,239.3935,619.7564,859.1499,IDHwt,NA,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,30,female,9.3965014,0,NA,18,0.078849057,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.321928095,Expressed,WT,WT,WT,WT,0.89,1.92,182.0756,188.3213,370.3969,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,37,female,63.5085217,1,NA,23,0.146852272,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.84,2.09,943.9701,2309.4127,3253.3828,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,21,male,0.0985647,0,NA,2,0.00022608,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,1,1.95,869.7413,1073.3682,1943.1094,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,40,female,21.4871046,0,NA,12,0.045596195,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.24,3.91,1913.062,1707.011,3620.073,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,34,female,32.9863196,0,NA,1,2.47E-05,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,97.64384,-416.1405,-318.49666,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,51,female,12.2220228,0,NA,68,0.192116008,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,4.906890596,Expressed,WT,WT,WT,WT,0.74,1.98,894.1018,1058.7995,1952.9013,IDHwt,CL,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,3.9309,2.0724Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,54,male,6.242431,0,NA,44,0.051046259,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.321928095,Expressed,WT,WT,WT,WT,0.73,3.8,226.2914,226.5727,452.8641,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,53,male,0.0985647,0,NA,18,0.011236364,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.2,3.68,2555.499,4314.654,6870.153,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,62,male,0.4599686,0,NA,1,0.000114912,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,1,3.96,469.9071,-234.0747,235.8324,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,26,female,2.4969724,0,NA,20,0.078899239,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,395.8596,1651.9154,2047.7749,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,64,male,3.942588,0,NA,24,0.056155754,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3,Expressed,WT,WT,WT,WT,0.66,1.89,244.8731,230.5522,475.4253,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,57,male,4.6982507,0,NA,37,0.139576987,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3,Expressed,WT,WT,WT,WT,0.57,1.88,949.3128,2791.2845,3740.5973,IDHwt,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,32,male,0.2299843,0,NA,9,0.04192296,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.44,4.03,669.2679,1484.9563,2154.2242,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,49,female,29.56941,0,NA,12,0.000219956,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,0.34,1.95,-82.20277,-493.23201,-575.43479,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G3,36,male,3.8768782,0,NA,15,0.054121194,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.63,1.98,1415.765,1924.197,3339.962,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,29,female,1.7084548,0,NA,2,9.61E-06,WT,non-codel,IDHwt,Unmethylated,NA,NA,WT,2.584962501,Expressed,WT,WT,WT,WT,NA,NA,154.2739,-568.4557,-414.1817,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,30,female,16.0331912,0,NA,27,0.173855384,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.47,1.94,2371.45,3758.848,6130.298,IDHmut-non-codel,ME,LGr4,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,47,male,15.7046422,0,80,544,0.71791584,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.66,3.39,718.7091,932.9413,1651.6505,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,55,female,0.2299843,0,NA,35,0.453851717,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,6.129283017,Expressed,WT,WT,WT,WT,0.58,8.33,399.1909,2435.5679,2834.7588,IDHwt,CL,LGr3,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,51,female,10.4807131,0,90,11,NA,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,1,Not expressed,WT,WT,WT,WT,NA,NA,477.9398,532.4329,1010.3727,IDHmut-codel,NE,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,33,female,0.1314196,0,NA,23,0.053485585,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1.584962501,Not expressed,Mutant,WT,WT,WT,0.21,4.2,828.0197,1658.4446,2486.4642,IDHmut-non-codel,NE,LGr4,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,33,female,13.9961874,0,90,16,0.166706894,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.88,3.98,270.9297,192.3577,463.2874,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm1,IDHmut-K1,G-CIMP-high,4.0557,8.9998Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,48,female,0.0657098,0,NA,32,0.170497979,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,7.199672345,Expressed,WT,WT,WT,WT,0.82,1.94,204.90421,-85.41543,119.48878,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,65,female,14.6861403,0,70,55,0.176037395,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,5.247927513,Expressed,WT,WT,WT,WT,0.85,1.97,1135.372,1464.576,2599.949,IDHwt,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,24,male,0.0985647,0,NA,20,0.030380511,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.84,1.92,110.7064,-275.0946,-164.3883,IDHmut-non-codel,PN,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,70,female,5.3224938,1,40,46,0.153035493,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,WT,9.076815597,Expressed,WT,WT,WT,WT,0.72,2.02,673.1624,1397.5288,2070.6911,IDHwt,CL,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,47,male,2.6941018,0,NA,27,0.111606586,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.8,1.94,251.574,685.7424,937.3164,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,38,female,13.0105404,0,90,31,0.087655604,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.700439718,Expressed,WT,WT,WT,WT,0.58,3.89,384.7102,1547.3574,1932.0676,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G2,36,female,1.8070195,0,NA,21,0.096253694,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.53,4.21,138.4204,-29.58615,108.83425,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,47,male,16.1317559,0,60,15,0.27192458,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,0,Not expressed,WT,WT,WT,WT,0.76,3.75,1302.938,2089.937,3392.874,IDHwt,CL,LGr4,IDHwt-R4,LGm4,IDHwt-K1,Classic-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,37,female,5.3224938,0,80,17,0.207254674,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.53,3.68,982.9614,2463.7013,3446.6627,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,51,female,14.2590266,0,NA,54,0.398900628,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,6.584962501,Expressed,WT,WT,WT,WT,0.9,3.67,-194.9804,-382.297,-577.2774,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G2,20,female,6.3738506,0,80,5,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,NA,NA,Mutant,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,IDHmut-non-codel,NA,NA,NA,LGm1,IDHmut-K1,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,39,0.273603335,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,6.129283017,Expressed,WT,WT,WT,WT,0.76,3.69,946.3083,2650.3379,3596.6463,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.226,2.4953Case Western - St Joes,Brain Lower Grade Glioma,oligodendroglioma,G3,66,male,3.3840547,0,100,41,0.173702651,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,6.209453366,Expressed,WT,WT,WT,WT,0.82,1.91,940.6951,1489.3967,2430.0918,IDHwt,NA,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,62,male,2.4312626,0,NA,47,0.182266266,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.69,3.92,1066.06,1684.914,2750.974,IDHwt,NE,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western - St Joes,Brain Lower Grade Glioma,oligoastrocytoma,G2,33,male,10.513568,0,NA,21,0.121027822,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.807354922,Expressed,Mutant,WT,WT,WT,0.78,2.06,269.1366,601.5718,870.7084,IDHmut-non-codel,PN,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACase Western - St Joes,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,31,0.191043477,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.754887502,Expressed,WT,WT,WT,WT,0.65,3.74,1216.9795,982.0646,2199.0441,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,15,0.113327617,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.321928095,Expressed,WT,WT,WT,WT,0.85,3.91,285.7512,310.1452,595.8964,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NACase Western - St Joes,Brain Lower Grade Glioma,astrocytoma,G3,34,male,0.0985647,0,NA,14,0.124899428,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.82,1.99,1187.639,2450.469,3638.108,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMSKCC,Brain Lower Grade Glioma,oligodendroglioma,G2,37,male,29.897959,0,NA,11,0.05102588,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.169925001,Expressed,WT,WT,WT,WT,0.56,1.95,568.7122,726.7324,1295.4446,IDHmut-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K3,Codel,6.9039,3.7721MSKCC,Brain Lower Grade Glioma,oligodendroglioma,G2,39,male,13.4376541,0,NA,18,0.115936384,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.906890596,Expressed,WT,WT,WT,WT,0.56,3.82,-261.5344,-308.8793,-570.4137,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,6.8801,3.7045MSKCC,Brain Lower Grade Glioma,oligoastrocytoma,G2,38,male,8.3122897,0,NA,16,0.055161054,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.5,3.95,230.7121,198.4189,429.131,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,3.1814,4.682MSKCC,Brain Lower Grade Glioma,astrocytoma,G2,41,male,19.2201165,0,NA,37,0.045930152,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.87,2.02,819.241,1213.437,2032.678,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMSKCC,Brain Lower Grade Glioma,oligodendroglioma,G2,35,male,40.1486878,0,NA,16,0.793083469,Mutant,codel,IDHmut-codel,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,4.807354922,Expressed,WT,WT,WT,WT,0.94,1.81,8.557895,-119.84964,-111.291745,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMSKCC,Brain Lower Grade Glioma,astrocytoma,G2,40,female,35.8775508,0,NA,NA,0.021753312,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,NA,NA,NA,WT,0.67,2.01,934.7228,1230.6414,2165.3642,NA,NE,LGr4,NA,LGm2,NA,NA,NA,NAMSKCC,Brain Lower Grade Glioma,oligodendroglioma,G2,45,female,4.3039919,0,NA,12,0.07838109,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.169925001,Expressed,WT,WT,WT,WT,0.72,1.97,268.7523,-397.3019,-128.5496,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,3.4226,2.6097MSKCC,Brain Lower Grade Glioma,astrocytoma,G3,34,female,21.684234,0,NA,34,0.089108122,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.8,2.03,95.20777,276.76185,371.96962,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAMSKCC,Brain Lower Grade Glioma,astrocytoma,G3,36,male,21.5856693,0,NA,22,0.012363122,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.33,3.75,521.9649,817.3169,1339.2818,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMSKCC,Brain Lower Grade Glioma,astrocytoma,G3,31,male,19.5815204,0,NA,28,0.111236242,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.74,1.93,735.7311,859.5918,1595.3229,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMSKCC,Brain Lower Grade Glioma,oligodendroglioma,G2,39,male,17.8073558,0,NA,17,0.095251982,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.754887502,Expressed,WT,WT,WT,WT,0.84,3.81,119.8998,367.5692,487.469,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAMSKCC,Brain Lower Grade Glioma,oligodendroglioma,G3,68,male,10.5464229,0,NA,39,NA,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.64385619,Expressed,WT,WT,WT,WT,NA,NA,-101.483293,96.580441,-4.902851,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMSKCC,Brain Lower Grade Glioma,astrocytoma,G3,64,male,12.7477012,1,NA,28,NA,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.169925001,Expressed,WT,WT,WT,WT,NA,NA,1107.581,2392.239,3499.82,IDHwt,CL,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMSKCC,Brain Lower Grade Glioma,astrocytoma,G2,42,female,20.7971517,0,NA,19,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,411.4286,736.2419,1147.6704,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMSKCC,Brain Lower Grade Glioma,astrocytoma,G2,35,male,20.698587,0,NA,16,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,1344.064,3344.653,4688.717,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAChristiana Healthcare,Brain Lower Grade Glioma,oligodendroglioma,G2,43,male,18.9901322,1,90,44,0.592213448,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,1,1.89,102.3293,205.2891,307.6184,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,5.4533,8.8434Christiana Healthcare,Brain Lower Grade Glioma,oligoastrocytoma,G3,62,male,42.7442249,0,NA,43,0.145369293,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,4.523561956,Expressed,WT,WT,WT,WT,0.8,1.95,327.9338,220.1289,548.0627,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAHartford,Brain Lower Grade Glioma,oligoastrocytoma,G3,26,male,5.2239291,0,90,9,0.116137358,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.459431619,Expressed,WT,WT,WT,WT,0.87,1.83,-13.42287,373.32176,359.89888,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAHartford,Brain Lower Grade Glioma,astrocytoma,G3,45,female,4.7311056,0,80,45,0.130743667,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,7.483815777,Expressed,WT,WT,WT,WT,0.88,2.09,191.2352,826.34,1017.5752,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G2,27,male,0,0,NA,20,NA,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,5.392317423,Expressed,WT,WT,WT,WT,NA,NA,-30.24247,-410.42066,-440.66313,IDHmut-codel,PN,LGr1,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G3,35,male,0,0,60,25,0.94152744,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.75,3.53,1188.422,2019.151,3207.573,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G2,39,male,0.2299843,0,60,64,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,199.5258,878.4083,1077.9341,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G2,20,female,6.7023996,0,80,16,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,NA,NA,399.2022,840.8788,1240.0811,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G3,41,female,1.642745,0,80,24,0.109116058,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.321928095,Expressed,WT,WT,WT,WT,0.71,1.9,1611.706,2654.43,4266.136,IDHmut-codel,ME,LGr4,IDHmut-R3,LGm2,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G2,21,male,2.3655528,0,NA,2,NA,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,410.2928,1030.4667,1440.7595,IDHwt,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,PA-like,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G3,39,male,2.299843,0,NA,27,NA,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,867.7829,1472.5438,2340.3267,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G2,33,male,4.1068625,0,80,24,0.106566657,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.584962501,Expressed,WT,WT,WT,WT,1,3.91,-464.1599,-676.6309,-1140.7908,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G2,30,male,5.8810271,0,NA,15,0.077460192,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,NA,NA,642.5387,1444.9127,2087.4514,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G2,36,female,7.6223368,0,80,25,0.107962707,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.61,3.86,-52.47105,-66.27413,-118.74518,IDHmut-non-codel,NE,LGr4,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G3,35,female,0.7556627,0,70,35,0.200138245,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.58,3.81,133.207,-233.6268,-100.4198,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G2,26,male,1.2813411,0,70,2,0.947727817,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,WT,WT,WT,WT,0.88,1.49,525.9717,957.3951,1483.3668,IDHwt,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G3,71,female,0.1642745,0,NA,54,0.151979395,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.46,2.01,1999.88,2220.083,4219.963,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G3,35,male,0.2956941,0,NA,38,0.234237275,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.81,3.72,46.88394,801.46771,848.35165,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G3,21,male,0.2628392,0,NA,8,0.015630592,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,1,1.96,1059.4724,838.9983,1898.4707,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,oligodendroglioma,G3,64,female,0.2628392,0,NA,28,0.14650225,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6.409390936,Expressed,WT,WT,WT,WT,0.97,1.88,-201.5331,-529.2546,-730.7877,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,oligoastrocytoma,G3,22,male,0.1971294,0,NA,20,0.051710168,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.754887502,Expressed,WT,WT,WT,WT,0.86,1.9,599.6173,241.5389,841.1562,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,oligoastrocytoma,G2,59,female,0.1971294,0,90,23,0.048414204,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,0.84,2.01,1045.9452,829.3091,1875.2543,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,astrocytoma,G2,52,female,0.2299843,0,NA,29,0.096148776,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.64,3.81,109.4423,285.0674,394.5097,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,25,0.030449278,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.89,2,-110.1999,359.7461,249.5462,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,17,0.025037894,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.33,4.06,1183.685,2321.752,3505.437,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,15,0.159786595,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.857980995,Expressed,WT,WT,WT,WT,0.93,1.89,-52.58409,186.72038,134.13629,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,23,0.248668103,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6.807354922,Expressed,WT,WT,WT,WT,0.68,3.69,-81.68947,-296.13139,-377.82086,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,27,0.092974385,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.84,1.93,-421.5276,-441.9525,-863.4801,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,43,0.268680193,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.58,3.75,983.9332,1022.8848,2006.818,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NACureline,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,10,0.063571302,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.76,1.94,233.5913,175.39,408.9813,IDHmut-codel,NE,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G3,38,female,5.7496075,0,100,26,0.077596028,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.73,3.84,134.39739,-17.63407,116.76332,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G2,32,female,2.5298273,0,90,20,0.203741253,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.54,3.89,400.1997,1063.4916,1463.6913,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G2,43,female,4.8296703,0,90,22,0.051166176,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.321928095,Expressed,WT,WT,WT,WT,0.71,1.95,221.9697,489.3129,711.2827,IDHmut-codel,NE,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G3,28,female,7.7866113,0,90,19,0.097244003,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.129283017,Expressed,WT,WT,WT,WT,0.89,1.99,905.964,962.0278,1867.9918,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G2,54,male,4.1068625,0,90,26,0.084857942,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,3.584962501,Expressed,WT,WT,WT,WT,1,3.71,-173.72443,-71.17119,-244.89562,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,astrocytoma,G3,41,male,4.1725723,0,90,14,0.252224894,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.92,5.75,NA,NA,NA,IDHwt,NA,NA,NA,LGm6,IDHwt-K3,PA-like,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G3,52,female,-0.0328549,0,90,12,0.078494406,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.72,1.97,455.4877,1220.026,1675.5137,IDHmut-codel,NA,LGr1,IDHmut-R3,LGm2,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G3,51,male,2.956941,0,90,56,0.483567114,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,5.129283017,Expressed,WT,WT,WT,WT,0.58,4.48,641.6412,1845.8393,2487.4804,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G3,43,male,-0.0328549,0,90,30,0.027403936,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,1,4,592.0986,1248.5634,1840.662,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAFondazione-Besta,Brain Lower Grade Glioma,astrocytoma,G2,66,male,-0.0328549,0,90,30,0.135368771,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.66,3.84,891.3603,1697.9595,2589.3198,IDHwt,CL,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G3,38,male,2.2012783,0,90,13,0.084864363,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,0.86,3.78,38.471,-97.42653,-58.95553,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G2,38,male,3.1540704,0,90,24,0.147335219,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.459431619,Expressed,WT,WT,WT,WT,0.85,3.75,-273.2364,-523.0857,-796.3221,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G2,27,male,0.5913882,0,90,18,0.035574972,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.86,1.96,207.7336,698.4155,906.1492,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G3,47,male,6.3081408,0,90,26,0.125484244,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6,Expressed,WT,WT,WT,WT,0.84,1.83,-287.829375,-2.954359,-290.783734,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G2,58,female,3.9097331,0,90,15,0.051051571,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.584962501,Expressed,WT,WT,WT,WT,0.7,1.95,149.7168,208.2416,357.9584,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G3,56,female,4.7311056,0,100,31,0.111957119,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.321928095,Expressed,WT,WT,WT,WT,0.83,1.88,53.65934,319.99059,373.64993,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G2,73,female,1.9055842,0,40,40,0.088688259,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.69,4.07,-166.73559,117.33673,-49.39886,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G2,23,female,0.2299843,0,100,13,0.027967542,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,Mutant,WT,WT,WT,0.41,3.98,329.5797,614.4205,944.0002,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAFondazione-Besta,Brain Lower Grade Glioma,astrocytoma,G3,48,male,5.0267997,0,70,56,0.144971914,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,4.392317423,Expressed,WT,WT,WT,WT,1,2.05,392.4691,926.26,1318.7291,IDHwt,CL,LGr4,IDHwt-R4,LGm4,IDHwt-K1,Classic-like,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligodendroglioma,G2,33,male,3.4826194,0,100,13,0.051615243,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.459431619,Expressed,WT,WT,WT,WT,NA,NA,-29.0059,50.23875,21.23285,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAFondazione-Besta,Brain Lower Grade Glioma,oligoastrocytoma,G3,38,female,0.0657098,0,80,18,0.084639632,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-248.84996,346.95677,98.10681,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMD Anderson,Brain Lower Grade Glioma,oligodendroglioma,G2,40,male,88.7739398,0,NA,22,0.064072395,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.700439718,Expressed,WT,WT,WT,WT,0.71,3.77,-121.2543,276.6889,155.4347,IDHmut-codel,NA,LGr3,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAMD Anderson,Brain Lower Grade Glioma,oligodendroglioma,G3,52,male,93.965014,0,NA,21,0.051661512,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4,Expressed,WT,WT,WT,WT,0.93,1.9,-71.61327,-273.91337,-345.52664,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMD Anderson,Brain Lower Grade Glioma,oligodendroglioma,G2,53,female,32.6249157,0,NA,29,0.051719419,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.74,1.95,431.135,633.3181,1064.4531,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAMD Anderson,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,9,0.084126158,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.92,1.92,208.8114,237.2211,446.0325,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMD Anderson,Brain Lower Grade Glioma,oligodendroglioma,G2,48,female,59.3359494,0,NA,27,0.080049059,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.906890596,Expressed,WT,WT,WT,WT,1,3.87,-342.9357,-293.9996,-636.9353,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,17,0.094564308,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5,Expressed,WT,WT,WT,WT,NA,NA,80.88039,-323.80773,-242.92733,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,34,0.051112385,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.754887502,Expressed,WT,WT,WT,WT,NA,NA,166.8854,852.5863,1019.4718,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,47,0.481405024,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-251.8399,915.2733,663.4334,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,18,0.116932649,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.700439718,Expressed,WT,WT,WT,WT,NA,NA,-300.2665,-129.9466,-430.2131,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,22,2.90E-05,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,NA,NA,198.021,419.0588,617.0798,IDHmut-non-codel,NA,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,25,0.055566103,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,-32.6404,238.3722,205.7318,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of California San Francisco,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,13,0.072512451,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,NA,NA,555.4194,890.1391,1445.5584,IDHmut-codel,NA,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,48,female,62.1286159,1,100,54,0.18057603,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.81,1.97,443.5725,923.8357,1367.4081,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,38,male,69.0281449,0,100,17,0.00773354,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.71,3.92,1060.112,1442.625,2502.738,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G3,50,male,18.7601479,0,90,33,0.127291493,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.86,1.85,1495.985,2537.252,4033.237,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G3,40,male,28.255214,0,90,28,0.228156338,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.86,5.65,844.344,624.1473,1468.4913,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G3,46,male,28.1237944,0,100,28,0.087623643,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.044394119,Expressed,WT,WT,WT,WT,0.82,1.87,468.3163,263.6467,731.963,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,50,male,22.4727516,0,100,19,0.201484614,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6.022367813,Expressed,WT,WT,WT,WT,0.85,2.06,-589.9953,-819.7747,-1409.77,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,39,female,21.6185242,0,100,26,0.064665464,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,0.72,3.91,533.4634,1008.5871,1542.0505,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,46,male,16.3617402,0,100,41,0.112146975,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,0.9,3.9,2042.886,2694.913,4737.798,IDHwt,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,22,female,11.3020856,0,100,9,0.027562355,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.26,3.98,451.4516,650.7018,1102.1535,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,48,female,15.6060775,0,100,24,0.078020866,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.321928095,Expressed,WT,WT,WT,WT,0.77,1.92,405.7214,618.9715,1024.6929,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,33,male,20.041489,0,100,17,0.051559708,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,NA,NA,307.5684,1410.3245,1717.893,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,28,male,9.85647,0,100,27,0.037587786,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.44,3.94,103.4483,306.9937,410.442,IDHmut-non-codel,NE,LGr3,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,24,male,94.5564022,0,100,17,2.44E-05,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.58,3.85,650.2193,1106.1417,1756.361,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,36,male,83.6485754,0,NA,20,0.052151901,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,1521.802,1883.875,3405.677,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,66,male,5.8481722,1,60,38,0.092071643,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,1,3.95,2127.33,3003.235,5130.565,IDHwt,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,52,male,103.6900644,0,100,28,0.07885906,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.64385619,Expressed,WT,WT,WT,WT,0.89,1.87,-355.7371,-546.656,-902.3931,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G3,58,male,62.3257453,0,100,33,0.151559989,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,1,4.73,-266.3974,-322.4232,-588.8206,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,34,male,72.5436192,0,100,12,0.05177428,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.88,1.9,226.4936,104.7483,331.2419,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,31,male,70.5066154,0,100,19,0.03095134,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.75,3.93,2342.068,2016.115,4358.183,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G2,73,female,22.8998653,0,80,41,0.200727387,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.86,3.92,-246.2392,-164.5912,-410.8304,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G2,56,female,70.6051801,0,100,10,6.44E-06,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,NA,NA,294.7206,-411.2752,-116.5545,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm1,IDHmut-K1,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,52,male,10.8749719,0,100,38,0.181996179,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,NA,NA,898.07057,32.47993,930.55049,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,59,female,9.2979367,0,90,56,0.546311489,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.169925001,Expressed,WT,WT,WT,WT,0.89,1.93,663.9415,1203.3324,1867.2739,IDHwt,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,38,female,9.0350975,0,90,28,0.084396756,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,0.47,1.92,1483.789,2291.52,3775.309,IDHmut-codel,ME,LGr4,IDHmut-R3,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,29,male,7.5894819,0,100,22,0.081271179,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.4,4.12,174.0632,1209.212,1383.2752,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G3,42,male,6.1438663,0,100,24,0.117547722,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.69,3.74,418.4105,1131.5689,1549.9793,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G2,57,female,3.3840547,0,100,34,0.053627981,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.48,3.95,660.6568,1510.209,2170.8657,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G2,45,female,14.2590266,0,100,11,0.115555544,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.321928095,Expressed,WT,WT,WT,WT,0.5,2.05,-103.8975,-815.7529,-919.6504,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,33,female,7.9180309,1,60,49,0.15322937,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.285402219,Expressed,Mutant,WT,WT,WT,NA,NA,412.2483,629.7599,1042.0082,IDHmut-non-codel,PN,LGr1,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,57,male,19.6143753,0,100,31,0.250674789,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.62,1.81,1148.301,1760.173,2908.474,IDHwt,CL,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G3,39,male,12.5834267,0,80,23,0.051094188,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.63,3.84,405.8279,1380.1902,1786.0181,IDHmut-codel,NA,LGr3,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,48,female,4.2054272,0,90,26,0.182389044,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.59,4.1,406.2001,1045.4782,1451.6783,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G3,30,female,9.3636465,0,100,45,0.287108414,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.85,3.89,-246.434229,237.415515,-9.018713,IDHmut-non-codel,PN,LGr1,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,43,male,8.1808701,0,60,18,0.059811569,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.321928095,Expressed,WT,WT,WT,WT,0.76,1.89,364.3265,383.8319,748.1585,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G3,25,male,2.0370038,0,80,9,0.051077223,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.906890596,Expressed,WT,WT,WT,WT,0.9,3.84,17.82582,-280.38214,-262.55633,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G3,52,female,8.1151603,0,100,17,0.084893707,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,0.78,2,140.721,517.3663,658.0873,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,54,female,3.5811841,0,100,36,0.168088017,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,1,2.12,-474.864,-303.7309,-778.5948,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,36,female,4.0411527,0,100,25,0.113471879,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.72,4,299.6171,1054.2315,1353.8486,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligoastrocytoma,G2,35,female,18.2016146,0,100,30,0.191986992,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.807354922,Expressed,WT,WT,WT,WT,0.69,1.96,-51.85031,-119.42679,-171.2771,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,41,male,13.0105404,0,100,38,0.078014839,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.321928095,Expressed,WT,WT,WT,WT,NA,NA,-130.5611,-656.4043,-786.9655,IDHmut-codel,PN,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,oligodendroglioma,G2,35,male,164.2745,0,90,11,0.161525604,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.74,3.92,-128.0103,-381.9901,-510.0003,IDHmut-codel,NE,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,69,male,10.3821484,1,90,35,0.146151008,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3,Expressed,WT,WT,WT,WT,1,3.91,871.3287,2240.3159,3111.6446,IDHwt,NA,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,28,female,87.0326301,0,100,28,0.062372911,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.74,3.96,574.5509,1164.6328,1739.1837,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,46,male,17.413097,0,90,24,0.002433157,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.74,3.94,1555.807,1324.712,2880.519,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G2,27,male,83.7471401,0,80,24,0.091200692,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.45,3.72,1705.799,2382.597,4088.395,IDHmut-non-codel,ME,LGr3,IDHmut-R3,LGm1,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,44,female,31.5735589,1,90,34,0.096570425,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,Mutant,WT,WT,WT,0.88,2.02,559.3419,1179.6675,1739.0094,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,70,male,18.6944381,0,80,35,0.084641472,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,490.1471,900.9415,1391.0886,IDHwt,NA,LGr4,IDHwt-R3,LGm6,IDHwt-K3,PA-like,NA,NADept of Neurosurgery at University of Heidelberg,Brain Lower Grade Glioma,astrocytoma,G3,40,male,4.9939448,0,70,57,0.216153571,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,1238.807,2169.255,3408.063,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G3,43,female,49.4137696,0,90,63,0.257747962,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,4,Expressed,WT,WT,WT,WT,0.89,2.08,482.3522,638.1994,1120.5515,IDHwt,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G2,39,female,35.9104057,0,90,36,0.092555588,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.68,1.98,-205.299,-205.9932,-411.2922,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligoastrocytoma,G2,30,male,25.298273,0,100,21,0.14286196,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6.189824559,Expressed,WT,WT,WT,WT,0.88,1.8,5.907922,-58.647443,-52.73952,IDHmut-codel,PN,LGr1,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G2,44,male,22.5713163,0,100,23,0.0570482,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.67,1.94,-141.33071,27.55052,-113.78019,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G2,41,female,48.3624128,0,100,22,0.106384249,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,0.62,3.96,-307.0312,-217.3752,-524.4064,IDHmut-non-codel,NE,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,5.152,8.0973The University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G3,40,male,11.9920385,0,90,41,0.204121994,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.459431619,Expressed,WT,WT,WT,WT,NA,NA,312.8619,236.193,549.0549,IDHwt,NA,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G2,32,male,15.0803991,0,80,16,7.96E-06,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,844.9278,1712.4812,2557.409,IDHwt,NA,LGr4,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G3,48,male,50.7279656,0,100,16,0.048662183,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.321928095,Expressed,WT,WT,WT,WT,NA,NA,1168.107,2758.197,3926.304,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligodendroglioma,G3,54,female,34.3333705,0,100,35,0.099367487,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.247927513,Expressed,WT,WT,WT,WT,NA,NA,-290.3582,-565.9032,-856.2614,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligoastrocytoma,G3,44,female,24.2469162,0,90,39,0.209591127,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-225.81034,130.97935,-94.83099,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G3,30,male,19.3515361,0,90,33,0.345452859,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-134.6491,694.2116,559.5625,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligodendroglioma,G3,63,male,17.4788068,0,80,43,0.153144192,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,6.426264755,Expressed,WT,WT,WT,WT,NA,NA,580.9971,-159.4372,421.5598,IDHwt,NA,LGr1,IDHwt-R3,LGm6,IDHwt-K3,PA-like,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligoastrocytoma,G2,31,male,40.8057858,1,90,22,0.039653472,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,982.4186,1359.9998,2342.4184,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligodendroglioma,G3,40,male,16.4931598,0,100,24,0.115725642,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,6.022367813,Expressed,WT,WT,WT,WT,NA,NA,-247.0549,-592.3433,-839.3983,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligodendroglioma,G3,61,female,29.897959,0,90,32,0.051036109,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,NA,NA,407.9721,702.0565,1110.0286,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,astrocytoma,G2,31,male,18.8915675,0,80,26,0.16947204,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,655.6754,1558.3655,2214.0408,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligodendroglioma,G2,46,male,9.4293563,0,80,3,0.085319165,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,NA,NA,178.1498,-506.1324,-327.9827,IDHmut-codel,NA,LGr2,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligodendroglioma,G3,36,male,4.5668311,0,80,11,0.083867719,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,NA,NA,204.3986,636.6414,841.04,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAThe University of New South Wales,Brain Lower Grade Glioma,oligoastrocytoma,G2,19,male,11.9920385,0,90,20,0.052406226,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,392.5766,788.1142,1180.6907,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,24,0.100654865,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.84,3.89,24.58342,817.60907,842.19249,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,26,0.051581078,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.76,3.79,343.8164,488.1611,831.9775,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,30,0.241858648,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.8,1.95,666.5423,1308.4942,1975.0366,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,17,0.131769403,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.84,1.98,139.7635,296.4071,436.1706,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,23,0.065425568,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.53,3.96,310.6945,1059.54,1370.2345,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,23,0.074577442,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.65,1.93,-19.14822,110.18875,91.04053,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,5.15,10.8207University of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,54,0.357320859,Mutant,non-codel,IDHmut-non-codel,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.92,3.95,-221.2776,-400.9112,-622.1889,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,20,0.098591377,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.584962501,Expressed,WT,WT,WT,WT,0.88,1.94,61.95763,-218.73079,-156.77316,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,20,0.078560585,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.459431619,Expressed,WT,WT,WT,WT,0.73,3.73,-78.87709,141.96148,63.0844,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,28,0.161085398,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.34,3.87,1184.2635,939.3928,2123.6562,IDHwt,NE,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,15,0.102237,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,5.781359714,Expressed,WT,WT,WT,WT,0.9,2,-316.3962,-710.0648,-1026.461,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,22,0.194818311,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.55,3.82,464.3584,1041.2494,1505.6078,IDHmut-non-codel,NE,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,18,0.053081364,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.392317423,Expressed,WT,WT,WT,WT,0.85,3.89,-24.70885,-354.20503,-378.91388,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,32,0.118344795,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.906890596,Expressed,WT,WT,WT,WT,0.94,1.9,98.60251,-242.05439,-143.45188,IDHmut-codel,PN,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,14,0.065648881,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,1,3.94,117.0196,115.4115,232.4311,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,4.1016,7.367University of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,29,0.15360983,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,1,3.87,783.7324,1790.702,2574.4344,IDHmut-non-codel,PN,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Sao Paulo,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,37,0.130375593,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,WT,WT,WT,WT,NA,NA,-51.83185,284.26963,232.43778,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,4.4631,10.4544Huntsman Cancer Institute,Brain Lower Grade Glioma,oligodendroglioma,G2,50,female,33.0520294,0,90,38,0.314365509,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,343.0064,714.8733,1057.8797,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,astrocytoma,G2,37,female,30.0622335,0,NA,3,0.062702728,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,NA,NA,1607.73,2914.311,4522.041,IDHwt,NA,LGr3,IDHwt-R2,LGm6,IDHwt-K3,PA-like,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,oligodendroglioma,G2,54,male,13.5033639,0,70,18,0.432549579,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,NA,NA,1055.943,1149.525,2205.469,IDHmut-non-codel,NA,LGr3,IDHmut-R2,LGm2,IDHmut-K3,Codel,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,oligodendroglioma,G3,33,male,0.0985647,0,NA,26,0.109335389,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,7.169925001,Expressed,WT,WT,WT,WT,NA,NA,-497.7867,-303.3798,-801.1665,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,astrocytoma,G3,58,male,7.885176,1,100,26,0.217355836,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,NA,NA,792.9534,1886.8046,2679.758,IDHwt,NA,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,oligodendroglioma,G2,25,male,26.7767435,0,90,10,0.051580303,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,NA,NA,719.8294,260.3075,980.1369,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm2,IDHmut-K3,Codel,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,39,0.361330062,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,771.7105,2386.6425,3158.353,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHuntsman Cancer Institute,Brain Lower Grade Glioma,astrocytoma,G2,24,female,10.9406817,0,90,15,0.017143189,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,778.5159,1381.9119,2160.4278,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NA John Wayne Cancer Center,Brain Lower Grade Glioma,oligoastrocytoma,G3,44,male,27.0395827,0,NA,27,0.1311745,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,NA,NA,490.4138,696.9403,1187.3541,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NA John Wayne Cancer Center,Brain Lower Grade Glioma,astrocytoma,G3,36,female,7.0309486,0,NA,11,0.127757066,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,275.1694,1213.0067,1488.1761,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NANorthwestern University,Brain Lower Grade Glioma,oligodendroglioma,G3,35,female,23.1955594,0,NA,40,0.086236429,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,4.754887502,Expressed,WT,WT,WT,WT,0.95,1.95,3.189778,-269.294287,-266.104509,IDHmut-codel,NA,LGr1,IDHmut-R1,LGm3,IDHmut-K3,Codel,NA,NANorthwestern University,Brain Lower Grade Glioma,astrocytoma,G3,66,male,8.0494505,1,NA,53,0.107532583,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,6.64385619,Expressed,WT,WT,WT,WT,NA,NA,354.4889,1592.5575,1947.0463,IDHwt,NA,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NAUniversity of Kansas,Brain Lower Grade Glioma,oligodendroglioma,G2,47,male,45.0440679,0,NA,23,0.062593112,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,NA,NA,-202.466,-436.7801,-639.2461,IDHmut-codel,NA,LGr2,IDHmut-R2,LGm3,IDHmut-K3,Codel,NA,NAGreenville Health System,Brain Lower Grade Glioma,astrocytoma,G2,65,male,5.256784,0,NA,39,0.161447534,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,444.5928,912.5768,1357.1696,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,astrocytoma,G3,32,female,43.9270013,0,100,34,0.120068227,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,1663.615,2276.399,3940.015,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,27,0.204846542,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,-158.1825,-547.2946,-705.4771,IDHmut-non-codel,NA,LGr2,IDHmut-R2,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,12,0.063879594,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-14.8515,629.2124,614.3609,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,8,0.164998317,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,618.5724,1461.291,2079.8634,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,24,0.052710092,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,352.8455,717.852,1070.6975,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,37,0.067446893,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,116.6838,924.9426,1041.6264,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAJohns Hopkins,Brain Lower Grade Glioma,NA,NA,NA,NA,NA,NA,NA,57,0.175593812,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,NA,NA,-363.2262,-119.8361,-483.0623,IDHmut-non-codel,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,44,female,11.7620542,1,80,NA,0.4249,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.49,3.47,NA,NA,NA,Classical,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,50,male,4.7311056,1,100,52,0.147988208,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.9,1.96,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,59,male,11.3349405,1,80,NA,0.117881415,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,56,female,18.3330342,1,80,NA,0.239054564,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.6,1.93,NA,NA,NA,Mesenchymal,ME,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,40,female,23.1627045,1,80,NA,0.257453671,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,1.89,NA,NA,NA,Proneural,NA,unclassified,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,61,female,10.5792778,1,80,NA,0.159619337,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.9,1.99,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,20,female,35.3847273,1,80,NA,0.2131371,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.92,1.94,NA,NA,NA,G-CIMP,PN,LGr4,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,18,female,20.698587,1,80,NA,0.61314995,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,1.88,NA,NA,NA,Proneural,PN,unclassified,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,25,male,82.5315088,1,100,NA,0.210571425,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,2.01,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,50,male,20.6000223,1,80,NA,0.172790476,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.84,2.04,NA,NA,NA,Classical,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,50,male,55.8204751,0,100,NA,0.213670085,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.83,1.95,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,43,female,77.6032738,1,80,NA,0.174349346,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.87,2.03,NA,NA,NA,Classical,CL,unclassified,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,38,female,20.1071988,1,80,NA,0.186982904,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,1.96,NA,NA,NA,Classical,NE,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,35,male,53.0606635,1,100,NA,0.336508382,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.79,3.81,NA,NA,NA,Proneural,PN,LGr3,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,47,male,42.71137,1,100,NA,0.215985841,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.2,4.45,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,27,male,24.5754652,1,80,NA,0.159871113,Mutant,non-codel,IDHmut-non-codel,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.87,1.86,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,33,female,12.156313,1,100,NA,0.161795767,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,1.94,NA,NA,NA,Classical,CL,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,39,male,90.5152495,1,100,NA,0.208086201,Mutant,codel,IDHmut-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,2.05,NA,NA,NA,G-CIMP,PN,LGr4,NA,LGm3,IDHmut-K3,Codel,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,54,male,2.8255214,1,100,29,0.16427307,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.43,1.94,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,60,male,14.127607,1,80,NA,NA,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.52,1.89,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,74,female,3.614039,1,80,NA,0.188533504,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.83,2.1,NA,NA,NA,Classical,ME,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,48,female,10.7106974,1,80,NA,0.179284592,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,2,NA,NA,NA,Classical,CL,unclassified,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,54,male,10.513568,1,60,NA,0.181728213,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.61,1.81,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,54,female,18.3001793,1,80,NA,0.17468023,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.94,2.02,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,61,male,6.8666741,1,60,NA,0.103762974,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,2,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,78,male,14.7189952,1,80,55,0.083556744,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.807354922,Expressed,WT,WT,WT,WT,0.7,1.99,1731.481,2092.535,3824.016,Proneural,ME,LGr3,IDHwt-R3,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,80,male,3.2197802,1,NA,NA,0.258624099,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.92,NA,NA,NA,Proneural,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,43,male,15.0803991,1,100,NA,0.423659392,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,2.41,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,49,male,12.5834267,1,80,NA,0.13178753,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.52,3.9,NA,NA,NA,Neural,PN,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,44,female,6.5381251,1,80,NA,0.205529853,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.53,2.25,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,62,female,2.4969724,1,80,54,0.325988625,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,4.392317423,Expressed,WT,WT,WT,WT,0.53,3.21,3537.918,3210.6,6748.518,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,66,female,19.8443596,1,80,NA,0.152110179,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.39,2.04,NA,NA,NA,Neural,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,28,female,8.3451446,1,80,NA,0.12729265,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.82,1.96,NA,NA,NA,G-CIMP,NE,LGr4,NA,LGm1,IDHmut-K1,G-CIMP-high,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,68,female,9.5607759,1,80,NA,0.222514926,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.67,1.93,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,66,female,6.0124467,1,80,NA,NA,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,2,NA,NA,NA,Proneural,NE,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,50,male,19.71294,1,100,NA,0.172465249,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.61,1.97,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,57,male,26.4153396,1,80,NA,0.150757476,WT,non-codel,IDHwt,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.7,1.94,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,31,female,28.6823277,0,80,NA,0.501569352,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.73,3.31,NA,NA,NA,Proneural,PN,LGr3,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,70,male,25.0354338,0,80,NA,0.169481762,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.68,2.08,NA,NA,NA,Classical,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,53,male,5.4867683,1,80,NA,0.141049303,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.7,2.01,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,68,female,10.185019,1,80,NA,0.577797439,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,1.99,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,63,male,20.8300066,1,80,NA,0.351285024,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.69,1.93,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,57,male,27.2367121,1,80,NA,0.32378597,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.51,1.86,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,28,male,89.6610221,1,80,NA,0.086282305,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.5,4.1,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,59,female,22.7027359,1,80,NA,0.130291135,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.95,NA,NA,NA,Neural,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,36,female,12.6162816,1,80,NA,0.170216818,Mutant,non-codel,IDHmut-non-codel,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.72,1.96,NA,NA,NA,G-CIMP,ME,LGr3,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,63,female,51.2864989,1,80,NA,0.118050127,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.45,1.99,NA,NA,NA,Mesenchymal,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,45,female,8.8051132,1,100,NA,0.411167139,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.55,2.9,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,27,female,57.7260593,0,80,NA,0.132101681,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.72,2.07,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,52,male,16.9531284,1,100,NA,0.158100848,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.69,2,NA,NA,NA,Neural,NE,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,46,male,3.4826194,1,80,NA,0.27033195,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.72,1.87,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,42,male,27.0067278,1,100,NA,0.132941763,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,2.02,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,29,female,64.9541373,1,80,NA,0.243684428,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.95,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,54,male,11.6634895,1,80,NA,0.630923266,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.77,3.43,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,56,male,17.6430813,1,80,NA,0.130448583,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.18,1.99,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,56,male,23.1627045,1,80,NA,0.195704766,NA,non-codel,NA,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.48,1.99,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,43,female,92.5851082,0,100,NA,0.825841217,WT,non-codel,IDHwt,Unmethylated,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.72,1.51,NA,NA,NA,Neural,CL,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,37,female,99.9117509,1,80,NA,0.16085076,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,1.96,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,52,male,15.6389324,1,80,NA,0.227486409,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.58,2,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,51,male,48.9209461,1,80,NA,0.192866067,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.91,2,NA,NA,NA,Mesenchymal,NA,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,36,female,16.5260147,1,NA,NA,0.214891735,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,1.97,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,54,male,16.9202735,1,NA,NA,0.12283837,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.92,2.03,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,14,male,17.7087911,1,NA,NA,0.740134054,NA,non-codel,NA,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.84,2.49,NA,NA,NA,Classical,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,68,male,10.7435523,1,NA,NA,0.229584167,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.93,2.13,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,26,male,14.456156,1,NA,NA,0.132488542,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,6.62,NA,NA,NA,Classical,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,78,female,3.9754429,1,NA,NA,0.50640838,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.8,5.69,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,50,female,13.8647678,1,NA,NA,0.184181344,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.68,2.11,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,57,male,14.1933168,1,80,NA,0.167714096,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,49,male,15.9346265,1,80,NA,0.153100846,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,2.03,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,40,male,12.2220228,1,80,NA,0.137991654,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.9,2.03,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,74,male,9.8893249,1,80,NA,0.190455336,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.46,1.92,NA,NA,NA,Proneural,PN,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,69,female,7.7209015,1,80,NA,0.37468282,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.81,1.94,NA,NA,NA,Neural,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,61,male,10.6121327,1,80,NA,0.37558445,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.49,1.85,NA,NA,NA,Proneural,PN,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,82,female,7.3266427,1,80,NA,0.070870903,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.52,2.04,NA,NA,NA,Mesenchymal,NE,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,51,female,15.9017716,1,80,NA,0.392556534,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.6,1.8,NA,NA,NA,Mesenchymal,NA,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,46,female,25.6925318,1,80,NA,0.326992304,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,4.05,NA,NA,NA,Mesenchymal,NA,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,77,female,4.3697017,1,NA,NA,0.200400412,NA,non-codel,NA,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.93,1.97,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,48,male,25.1011436,1,80,NA,0.13822956,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.51,1.99,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,41,male,10.5792778,1,80,NA,0.021881454,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.35,2.03,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,67,male,12.3862973,1,80,NA,0.11696737,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,1.89,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,50,male,14.4890109,1,80,NA,0.137207042,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.82,1.93,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,67,female,10.5464229,1,100,NA,0.18278246,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.96,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,36,male,47.0810717,1,80,NA,0.167607547,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,3.81,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,70,female,0.657098,1,80,NA,0.170119694,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,62,male,11.3349405,1,80,NA,0.149924943,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.96,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,61,male,9.2650818,1,80,NA,0.193478742,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.66,1.96,NA,NA,NA,Proneural,NE,LGr1,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,62,female,16.1974657,1,80,NA,0.218283143,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.66,2.03,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,67,female,3.3511998,1,60,NA,0.261013476,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.45,1.89,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,61,male,16.7888539,1,80,NA,0.568422516,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.96,1.93,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,57,male,12.9119757,1,60,54,0.114035451,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.53,2.01,NA,NA,NA,Mesenchymal,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAMD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,43,male,15.3103834,0,80,31,0.295886312,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,3.459431619,Expressed,Mutant,WT,WT,WT,0.73,2.04,1448.181,1816.812,3264.993,G-CIMP,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,6.0662,4.6869MD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,53,male,15.441803,0,80,58,0.188306195,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,7,Expressed,WT,WT,WT,WT,0.93,2.02,796.9518,1115.6961,1912.6479,Classical,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,6.0381,15.2656MD Anderson Cancer Center,Glioblastoma multiforme,glioblastoma,G4,64,male,16.1974657,0,80,61,0.204362823,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.73,1.9,1615.791,3460.244,5076.035,Mesenchymal,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,81,female,2.6941018,1,NA,43,0.151734048,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm6,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,84,female,6.1438663,1,NA,85,0.197177695,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.69,1.95,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,67,male,20.370038,1,NA,63,0.176404315,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,NA,NA,WT,WT,WT,NA,0.61,1.96,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,3.2392,2.6509Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,female,47.5738952,1,60,68,0.152158906,WT,non-codel,IDHwt,Methylated,No combined CNA,Gain chr 19/20,Mutant,7.285402219,Expressed,WT,WT,WT,WT,0.9,2.04,757.6933,853.9367,1611.6301,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,6.4733,2.31Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,86,male,6.9323839,1,60,59,0.165720659,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.82,2.03,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,67,male,3.9754429,1,60,NA,0.101566118,WT,non-codel,IDHwt,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.63,1.99,NA,NA,NA,Classical,NE,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,66,male,22.7027359,1,80,43,0.244674062,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,Mutant,NA,NA,WT,WT,WT,NA,0.79,1.98,NA,NA,NA,G-CIMP,PN,unclassified,NA,LGm1,IDHmut-K1,G-CIMP-low,7.6244,1.9312Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,30,male,33.6434176,1,100,40,0.17797196,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.92,1.98,404.559,2285.346,2689.905,G-CIMP,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,54,male,12.9448306,1,80,27,0.286963169,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,6.303780748,Expressed,WT,WT,WT,WT,0.28,3.46,3208.683,4191.894,7400.577,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,49,male,25.3311279,1,NA,23,NA,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.27,1.95,2673.823,3265.7,5939.523,Neural,NE,LGr2,IDHwt-R4,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,male,14.2918815,1,NA,NA,0.274399282,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.56,2.21,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,female,26.6781788,1,NA,76,0.172705803,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.92,2.02,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,43,male,24.2140613,1,80,NA,0.182235863,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.64385619,Expressed,NA,NA,NA,WT,NA,NA,1933.911,2568.595,4502.505,Neural,ME,LGr4,IDHwt-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,40,male,11.8934738,1,60,1,2.12E-05,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,86,male,0.1971294,1,90,42,0.164336194,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.58,1.97,NA,NA,NA,NA,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,62,male,10.2835837,1,80,5,0.04743409,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,2.584962501,Expressed,WT,WT,WT,WT,0.17,2.1,2405.103,3456.884,5861.987,Mesenchymal,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,81,male,2.2012783,1,NA,1,0.001318189,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.21,2.01,NA,NA,NA,NA,NE,LGr2,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,58,male,11.7291993,1,60,NA,0.133053702,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.63,1.98,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,53,female,2.3326979,1,NA,93,0.149645328,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.83,2.01,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,6.2408,1.3743Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,33,female,20.0743439,1,NA,NA,0.132166913,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,51,female,17.7745009,1,NA,NA,0.144901546,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,male,10.0864543,1,NA,NA,0.156514368,WT,non-codel,IDHwt,Unmethylated,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,1,2.03,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,74,female,8.6079838,1,80,NA,0.183940558,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.73,2.06,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,45,male,19.4501008,1,NA,NA,0.173628169,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,32,female,46.5553933,1,70,18,0.723186271,Mutant,non-codel,IDHmut-non-codel,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,Mutant,NA,0.63,2.39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,68,male,12.3205875,1,NA,65,0.349369074,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.65,3.77,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,6.5201,6.7009Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,54,male,13.9304776,1,100,60,0.147727858,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,61,male,10.4478582,1,80,71,0.130333467,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.8,2.03,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K2,Mesenchymal-like,6.7316,5.5551Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,57,male,5.8481722,1,NA,NA,NA,Mutant,NA,NA,NA,NA,NA,NA,4.906890596,Expressed,NA,NA,NA,WT,NA,NA,1563.161,2334.814,3897.975,Proneural,ME,LGr4,IDHmut-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,female,3.1869253,1,40,54,0.150093889,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,4.523561956,Expressed,WT,WT,WT,WT,0.82,2.02,1478.51,1989.391,3467.901,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,5.1947,7.9907Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,73,male,10.8092621,1,80,52,0.20354741,WT,non-codel,IDHwt,NA,No combined CNA,Gain chr 19/20,NA,2.321928095,Expressed,WT,WT,WT,WT,0.79,1.92,1336.864,2129.393,3466.257,Classical,CL,LGr4,IDHwt-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,74,male,9.4293563,1,90,NA,NA,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.62,1.83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,56,female,11.7949091,1,NA,NA,NA,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NE,LGr2,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,47,female,3.4169096,1,60,NA,0.386795004,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.67,1.85,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,47,male,56.8718319,1,100,NA,0.242574937,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.58,1.95,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,52,male,10.6449876,1,90,0,NA,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,51,male,5.8481722,1,NA,34,0.488051751,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.62,1.76,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,44,male,11.4006503,1,90,0,NA,WT,NA,NA,NA,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NE,LGr2,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,59,female,19.6472302,1,100,46,0.260023175,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.68,1.97,2087.319,2709.595,4796.915,Mesenchymal,ME,LGr4,IDHwt-R4,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,68,male,3.28549,1,80,54,0.130610833,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.55,2.01,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,65,male,13.1091051,1,100,46,0.189859392,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,NA,NA,WT,WT,WT,NA,0.67,1.85,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,6.3329,2.3549Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,72,female,4.4682664,1,NA,73,0.177899353,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.86,2.05,NA,NA,NA,Neural,NA,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,54,male,3.2197802,1,80,73,0.133599512,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.491853096,Expressed,WT,WT,WT,WT,0.94,1.97,891.0307,854.4623,1745.493,Proneural,PN,LGr1,IDHwt-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,69,male,4.0411527,1,100,NA,0.259767587,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.73,2.02,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,34,male,51.3193538,0,80,NA,0.086830428,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,male,4.1725723,1,60,NA,0.588146746,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.82,3.43,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,38,male,53.9477458,0,NA,0,0.203393087,Mutant,non-codel,IDHmut-non-codel,NA,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,1217.688,2071.679,3289.367,Neural,PN,LGr4,IDHmut-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,male,20.2386184,1,60,NA,0.143054316,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.38,2.05,NA,NA,NA,Neural,NE,LGr2,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,male,3.6468939,1,60,NA,0.284326077,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.9,2.14,NA,NA,NA,Neural,CL,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,male,40.3458172,0,80,55,NA,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.459431619,Expressed,WT,WT,WT,WT,0.61,1.82,2217.525,3050.232,5267.756,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,54,male,36.9946174,0,100,58,0.228398313,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.79,3.94,NA,NA,NA,Neural,CL,LGr4,NA,NA,NA,NA,5.84,10.9089Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,69,male,27.2038572,1,60,NA,0.18099369,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,4.392317423,Expressed,NA,NA,NA,WT,0.87,1.93,1411.567,2312.712,3724.279,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,71,male,28.4523434,0,100,52,0.465363198,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.82,1.87,NA,NA,NA,Neural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,55,male,15.4089481,1,NA,5,NA,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.2,2.07,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,62,male,10.4150033,1,80,56,0.169736285,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,2.584962501,Expressed,WT,WT,WT,WT,0.57,1.88,2874.33,2820.935,5695.265,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,4.6853,4.2007Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,58,male,18.3001793,0,100,65,0.244174274,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.6,2.05,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,37,female,4.6653958,1,NA,NA,0.141439542,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.52,1.97,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,male,7.3923525,1,100,73,0.540978071,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.69,3.2,NA,NA,NA,Neural,NE,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,65,female,5.5524781,1,NA,NA,0.191535226,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.58,1.89,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,51,female,0.3942588,1,NA,NA,0.155120185,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.46,1.98,NA,NA,NA,Mesenchymal,NE,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,40,male,7.6551917,1,NA,NA,0.257132198,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.62,2.05,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,52,female,8.4108544,1,80,NA,0.138575889,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.73,1.98,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,6.7685,1.528Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,male,7.6223368,1,NA,66,0.492234921,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,1,4.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,72,female,7.3923525,1,NA,53,0.195671353,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.754887502,Expressed,WT,WT,WT,WT,0.46,1.96,1445.671,2569.344,4015.014,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,6.0767,2.7628Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,47,male,11.827764,1,100,62,0.210388757,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,6.266786541,Expressed,WT,WT,WT,WT,0.86,1.98,897.4022,1333.8326,2231.2348,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,5.2201,4.8623Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,55,female,0.5256784,1,NA,59,0.16261596,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.64,2.05,NA,NA,NA,Neural,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,66,male,15.0146893,1,100,56,0.210430269,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,NA,NA,WT,WT,WT,NA,0.66,1.84,NA,NA,NA,Neural,ME,LGr4,NA,NA,NA,NA,6.0758,2.1719Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,61,female,24.1483515,1,80,61,0.622491835,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.91,1.89,NA,NA,NA,Proneural,CL,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,67,male,0.7228078,1,NA,42,NA,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.65,1.84,1110.752,2102.384,3213.136,Neural,NE,LGr4,IDHwt-R4,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,31,male,19.8115047,1,100,22,0.174584443,Mutant,non-codel,IDHmut-non-codel,NA,No combined CNA,No chr 19/20 gain,WT,NA,NA,Mutant,WT,WT,NA,0.82,1.97,NA,NA,NA,Neural,NE,unclassified,NA,NA,NA,NA,6.8598,12.8147Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,75,female,13.6347835,1,NA,41,0.422394089,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.86,1.94,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,46,male,13.3062345,1,80,36,0.168375025,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.807354922,Expressed,WT,Mutant,WT,WT,0.78,1.99,1285.545,2238.704,3524.249,Proneural,PN,LGr1,IDHwt-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,57,male,20.4028929,1,90,0,NA,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NE,LGr2,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,65,female,14.9489795,0,100,58,0.170176032,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.9,1.95,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,51,male,10.8092621,1,NA,NA,0.142822245,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.6,2.02,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,57,female,9.0022426,1,NA,NA,0.180393426,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,2.11,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,71,male,0.2628392,1,NA,NA,0.214858787,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.94,2.05,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,43,male,72.3136349,1,NA,NA,0.462606187,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.37,3.54,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,female,4.6982507,1,NA,NA,0.646421503,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,3.3,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,56,female,9.5607759,1,NA,NA,0.162830795,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,2.01,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,77,female,3.1540704,1,NA,NA,0.169777944,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.87,2.16,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,male,35.0890332,1,NA,NA,0.629451537,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,3.4,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,71,male,12.3205875,0,80,60,0.258865193,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,Mutant,WT,0.62,2.02,2741.543,2714.843,5456.386,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,55,female,5.7496075,1,NA,56,0.202674785,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,4.169925001,Expressed,WT,WT,WT,WT,0.64,2.15,2806.428,3524.637,6331.065,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,60,male,5.7496075,1,80,39,0.16505126,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.554588852,Expressed,WT,WT,WT,WT,0.84,1.94,1412.965,2502.084,3915.05,Proneural,ME,LGr4,IDHwt-R3,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,77,male,9.7907602,1,80,62,0.198242568,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.88,2,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,4.3388,3.8863Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,73,female,2.1027136,1,NA,93,0.363515159,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.62,1.91,1893.586,2719.943,4613.529,Neural,ME,LGr4,IDHwt-R2,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,39,female,23.5569633,1,NA,21,0.066031814,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.24,2.03,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,53,male,9.3965014,0,NA,54,0.277582116,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,5.392317423,Expressed,WT,WT,WT,WT,0.85,2.06,1159.714,1451.667,2611.381,Proneural,PN,LGr1,IDHwt-R3,NA,NA,NA,6.0293,1.9881Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,69,male,22.3084771,0,100,98,0.227806301,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,5.087462841,Expressed,WT,WT,WT,WT,0.85,2.05,978.7484,1819.3433,2798.0918,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,66,male,19.5486655,0,80,71,0.201932279,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,6.857980995,Expressed,WT,WT,WT,WT,0.89,2.01,970.7951,1349.2375,2320.0326,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,5.5283,4.0336Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,59,male,7.8523211,1,80,51,0.229790148,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.169925001,Expressed,WT,WT,WT,WT,0.81,1.94,1581.389,2061.75,3643.139,Proneural,ME,LGr4,IDHwt-R3,NA,NA,NA,7.6428,3.0644Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,53,male,2.6941018,1,80,82,0.167392329,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,5.857980995,Expressed,WT,WT,WT,WT,0.91,2,295.3273,973.1127,1268.4401,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,50,male,2.6941018,1,NA,49,0.156272024,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2.584962501,Expressed,WT,WT,WT,WT,0.57,1.95,981.3623,2495.8744,3477.2366,Neural,NE,LGr4,IDHwt-R4,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,43,male,0.9199372,1,80,38,0.192514986,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.169925001,Expressed,WT,WT,WT,WT,0.72,1.92,2199.256,2533.086,4732.342,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,61,female,9.1665171,0,80,68,0.275076834,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.74,3.91,NA,NA,NA,Proneural,PN,LGr1,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,72,female,8.9036779,0,80,66,0.135976295,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.77,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,78,male,6.7023996,0,NA,81,0.275943701,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,NA,NA,WT,WT,WT,NA,0.78,2.18,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,6.4159,4.1952Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,74,male,7.1623682,0,80,38,0.216829064,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.95419631,Expressed,WT,WT,WT,WT,0.76,1.91,1684.457,2361.4,4045.857,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,52,male,22.9655751,0,80,52,0.217713573,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.77,2.09,NA,NA,NA,Classical,ME,LGr4,NA,LGm5,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,50,male,5.8481722,0,80,2,0.001109495,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.37,2.01,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,5.5188,4.0657Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,30,male,5.4210585,0,60,35,0.166447943,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.52,1.98,1685.136,2686.366,4371.502,Neural,ME,LGr4,IDHwt-R4,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,79,female,20.9285713,0,80,74,0.135197707,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.63,1.97,NA,NA,NA,Neural,NE,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,54,male,7.4252074,0,80,NA,0.290081703,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.48,2.01,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,42,male,6.8338192,1,80,NA,0.374190869,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,3.24,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,NA,NA,6.074,8.5018Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,75,male,4.0411527,1,60,NA,0.643497305,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.97,3.41,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,61,male,26.7767435,1,60,NA,0.244381189,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,1.93,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,56,female,8.6408387,0,80,NA,0.154246467,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,1.96,NA,NA,NA,Proneural,PN,LGr1,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,61,male,7.885176,0,80,NA,0.202966942,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.71,1.96,NA,NA,NA,Mesenchymal,ME,LGr1,NA,LGm4,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,81,female,13.6019286,1,NA,87,0.163400697,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.82,1.95,700.3666,1407.3398,2107.7063,Classical,NA,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,28,female,4.2054272,0,80,NA,0.101999934,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.72,1.95,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,47,male,15.3103834,1,90,24,0.197371883,WT,non-codel,IDHwt,Unmethylated,No combined CNA,Gain chr 19/20,NA,NA,NA,WT,WT,Mutant,NA,0.56,2.22,NA,NA,NA,NA,NA,NA,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,male,1.0842117,1,40,48,0.272115087,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,Mutant,5.977279923,Expressed,WT,WT,WT,WT,0.72,2.01,1822.699,3250.807,5073.506,Mesenchymal,ME,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,4.842,2.0718Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,75,female,12.484862,1,60,70,0.216156403,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.807354922,Expressed,WT,WT,WT,WT,0.82,1.92,1464.606,1542.576,3007.183,Proneural,PN,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,83,male,4.928235,1,60,58,0.121609081,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,6.108524457,Expressed,WT,WT,WT,WT,0.9,2,1143.688,1400.883,2544.571,Proneural,ME,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,53,female,9.2650818,0,80,38,0.309676446,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.44,3.84,1245.329,2494.923,3740.253,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,81,male,2.8255214,0,80,64,0.198867899,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.754887502,Expressed,WT,WT,WT,WT,0.74,2.02,1692.597,1981.129,3673.726,Mesenchymal,ME,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,72,female,8.5094191,0,80,76,0.169662868,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,6.339850003,Expressed,WT,WT,WT,WT,0.86,2.05,1207.333,1606.646,2813.979,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,50,male,5.9467369,0,100,64,0.112195636,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,9.523561956,Expressed,WT,WT,WT,WT,0.78,2.05,1226.984,1966.444,3193.428,Classical,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,59,male,6.8009643,0,100,45,0.140426778,WT,non-codel,IDHwt,Methylated,No combined CNA,Gain chr 19/20,NA,5.614709844,Expressed,WT,WT,WT,WT,0.91,1.97,858.893,1400.377,2259.27,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,23,female,5.9795918,1,80,NA,0.081574215,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.71,1.96,NA,NA,NA,Neural,NE,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,65,male,4.3697017,1,80,61,0.176738054,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.700439718,Expressed,WT,WT,WT,WT,0.8,1.96,1549.738,2435.354,3985.093,Neural,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,24,female,0.4271137,0,80,29,0.547758171,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.93,2.24,1450.1645,177.5786,1627.7431,Mesenchymal,NA,LGr4,IDHwt-R2,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,21,female,9.3636465,0,100,31,0.093933249,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.9,1.97,1475.984,1979.601,3455.585,G-CIMP,PN,LGr1,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,7.4459,9.4949Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,54,female,11.7291993,1,80,44,0.241895201,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.754887502,Expressed,WT,WT,WT,WT,0.87,1.92,884.7049,1415.3424,2300.0472,Classical,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,72,female,3.5483292,1,60,7,6.78E-06,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,0.18,1.98,3236.487,4285.207,7521.694,Mesenchymal,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,51,male,8.3451446,1,80,28,0.142673699,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,2,Expressed,WT,WT,WT,WT,0.64,1.97,1408.257,1543.883,2952.14,Neural,NE,LGr2,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,7.3688,2.4553Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,78,female,4.5339762,1,80,43,0.185223161,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,2,Expressed,WT,WT,WT,WT,0.28,1.92,2733.332,3346.174,6079.506,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,67,male,8.8051132,0,60,47,0.179870104,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.459431619,Expressed,WT,WT,WT,WT,0.74,1.92,2186.05,2425.231,4611.28,Neural,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,61,male,8.9693877,0,80,37,0.186463606,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,4.95419631,Expressed,WT,WT,WT,WT,0.78,2.04,1268.508,2520.512,3789.02,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,60,male,8.542274,0,100,47,0.255676829,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,5.426264755,Expressed,WT,WT,WT,WT,0.83,2.02,808.8111,1142.4896,1951.3007,Classical,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,5.5782,3.0986Henry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,23,female,6.7023996,0,80,NA,0.368235445,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,NA,NA,NA,WT,0.79,3.76,95.9,233.8489,329.7489,Proneural,PN,LGr1,NA,LGm6,NA,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,45,female,5.0925095,0,80,56,NA,Mutant,NA,NA,Methylated,NA,NA,NA,2,Expressed,Mutant,WT,WT,WT,NA,NA,258.5276,510.0708,768.5984,G-CIMP,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,NA,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,75,female,2.7269567,1,60,48,0.165795038,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,6.06608919,Expressed,WT,WT,WT,WT,0.8,2,1135.569,2180.949,3316.518,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,58,male,3.7454586,1,NA,45,0.769065386,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.392317423,Expressed,WT,WT,WT,WT,0.9,1.74,1366.632,1876.881,3243.513,Classical,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,45,female,6.1438663,0,100,190,0.079989319,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.85,1.08,1463.108,1933.683,3396.791,Mesenchymal,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,63,male,4.5668311,0,40,45,0.904751684,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,0.78,1.81,799.9301,2185.0271,2984.9572,Neural,ME,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,female,5.2239291,1,80,51,0.165581809,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,Mutant,WT,WT,NA,0.76,2.03,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,49,female,7.7866113,0,100,32,0.281167919,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.41,1.7,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm1,IDHmut-K1,G-CIMP-high,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,58,male,5.3882036,1,80,39,0.245692181,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.45,3.79,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,44,female,1.4784705,1,NA,59,0.104278875,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.39,2.19,NA,NA,NA,Proneural,PN,LGr2,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,female,120.4789183,1,NA,51,0.428330416,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.88,1.84,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,female,7.3594976,1,NA,80,0.402011458,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.72,3.7,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,male,8.3122897,0,40,59,0.171501162,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.85,2.04,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,65,male,12.8462659,0,80,58,0.204752269,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.47,2,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,53,female,4.7639605,0,NA,32,0.274207541,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.87,1.14,NA,NA,NA,NA,NA,NA,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,58,female,1.5441803,0,NA,59,0.164502937,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.92,1.98,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,76,male,4.7639605,0,100,46,0.116694689,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.52,2.02,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,60,male,4.9610899,0,NA,35,0.049813562,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.77,2,NA,NA,NA,NA,NA,NA,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,21,female,4.6982507,0,90,33,0.235417973,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,78,female,1.8727293,1,NA,75,0.323404042,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,79,male,3.1212155,1,NA,59,0.198857045,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,53,female,2.5626822,1,60,35,0.261902058,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,glioblastoma,G4,64,male,5.3882036,0,70,57,0.194409622,WT,non-codel,IDHwt,Methylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAHenry Ford Hospital,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,29,0.185548472,Mutant,non-codel,IDHmut-non-codel,Methylated,NA,NA,NA,NA,NA,Mutant,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm1,IDHmut-K1,G-CIMP-high,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,62,male,22.669881,1,80,NA,0.186569053,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.81,1.99,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,31,female,37.8159899,1,80,NA,0.868043945,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,1.8,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,57,female,4.1725723,1,80,NA,0.556355107,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.7,2.79,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,66,male,115.7806676,1,80,NA,0.061456543,Mutant,codel,IDHmut-codel,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.94,1.94,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,71,female,1.7413097,1,60,NA,0.175524431,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.62,2.07,NA,NA,NA,Proneural,PN,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,69,male,8.4108544,1,80,NA,0.254631672,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.61,2.16,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,50,male,25.6925318,1,100,NA,0.150056258,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.7,1.96,NA,NA,NA,Proneural,PN,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,63,male,12.156313,1,80,NA,0.170365904,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.77,1.93,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,46,male,9.7907602,1,NA,NA,0.254657044,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.8,1.94,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,32,male,29.2080061,1,80,NA,0.202727258,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.84,2.17,NA,NA,NA,G-CIMP,PN,LGr3,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,40,male,65.2826863,1,80,NA,0.111350115,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.71,2.04,NA,NA,NA,G-CIMP,NE,LGr3,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,79,male,1.2813411,1,NA,NA,0.157783945,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.6,2.1,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,58,male,8.4108544,1,80,NA,0.138374621,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,1.99,NA,NA,NA,Proneural,PN,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,52,female,17.9387754,1,60,NA,0.164389759,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.76,2,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,30,female,24.5426103,1,100,NA,0.22860422,WT,non-codel,IDHwt,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.81,1.99,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,59,female,31.0807354,1,80,NA,0.15538647,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.69,2.04,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,49,male,37.5531507,1,80,NA,0.144824346,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.75,2.01,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,50,male,22.2756222,1,80,NA,0.172020946,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,1.97,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,59,female,3.3840547,1,NA,NA,0.179683374,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.73,1.92,NA,NA,NA,Proneural,NE,LGr1,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,76,male,15.3760932,1,80,NA,0.217186683,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,69,male,4.4025566,1,NA,NA,0.191330969,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,51,female,12.2220228,1,100,NA,0.198221793,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.89,1.99,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,74,female,14.9161246,1,80,NA,0.173986381,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.33,1.99,NA,NA,NA,Neural,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,71,male,2.6941018,1,60,NA,0.116420945,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,74,male,18.0044852,1,80,8,0.561115192,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.491853096,Expressed,WT,WT,WT,WT,0.89,1.96,731.0701,701.9286,1432.9988,Neural,NA,LGr4,IDHwt-R2,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,59,male,15.3432383,1,80,NA,0.151979726,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.96,NA,NA,NA,Neural,NE,LGr1,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,69,male,13.9633325,1,60,NA,0.156500565,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.5,1.96,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,60,male,0.7228078,1,NA,NA,0.196879907,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.82,1.98,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,63,male,12.5505718,1,60,NA,0.168880099,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.47,1.98,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,75,male,4.271137,1,80,NA,0.527822574,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.52,3.58,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,69,male,7.7209015,1,80,NA,0.148517489,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,48,male,42.1199818,1,100,NA,0.192857962,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.46,1.8,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,69,female,11.0721013,1,40,NA,0.202472215,NA,non-codel,NA,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.85,1.96,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,14,male,19.5815204,1,NA,NA,0.47929938,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.94,1.96,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,34,female,58.6459965,1,80,NA,0.457128641,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,1.88,NA,NA,NA,G-CIMP,PN,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,60,female,19.3186812,1,80,NA,0.184121542,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.95,2.08,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,70,male,10.7435523,1,NA,NA,0.327383841,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.81,1.88,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,17,male,4.7968154,1,60,NA,0.046589895,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,2,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,61,male,20.8628615,1,80,NA,0.207668481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,17,female,7.2609329,1,80,NA,0.12258477,NA,non-codel,NA,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,2.11,NA,NA,NA,Proneural,PN,LGr1,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,52,male,15.9674814,1,80,NA,0.336290479,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.84,1.88,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,56,female,18.398744,1,80,NA,0.153048156,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.87,2.09,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NAUCSF,Glioblastoma multiforme,glioblastoma,G4,64,male,7.556627,1,80,NA,0.289670568,NA,non-codel,NA,NA,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.88,2.04,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,78,female,15.3432383,1,60,63,0.322119041,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.83,1.92,NA,NA,NA,Classical,NA,NA,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,36,female,14.7189952,1,100,37,0.182483735,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,5.727920455,Expressed,WT,WT,WT,WT,0.88,1.9,665.4355,1852.6959,2518.1315,Proneural,PN,LGr1,IDHwt-R3,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,49,male,12.9776855,1,60,35,0.168421176,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.64385619,Expressed,WT,WT,WT,WT,0.96,2,369.552,437.4202,806.9722,Proneural,PN,LGr1,IDHwt-R3,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,60,male,34.8919038,1,80,58,0.507591755,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.392317423,Expressed,WT,WT,WT,WT,0.8,1.91,1728.547,2673.784,4402.331,Mesenchymal,ME,LGr4,IDHwt-R2,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,57,male,10.4478582,1,100,NA,0.166341941,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.7,1.94,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,0.154255814,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,48,female,7.5894819,1,NA,NA,0.223673335,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.65,1.99,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,48,female,94.7206767,1,80,NA,0.174356785,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.68,1.99,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,69,male,0.0985647,1,NA,NA,0.143040216,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.86,2.03,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,51,male,38.1445389,1,80,NA,0.249944659,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.7,2.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,60,male,25.955371,1,100,NA,0.202934445,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.89,2,NA,NA,NA,Neural,NE,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,74,male,26.6453239,1,100,58,0.14545233,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.81,2.03,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,63,male,12.1234581,1,100,NA,0.387336709,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.82,2.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,75,female,3.6468939,1,60,62,0.189063194,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.88,2.01,NA,NA,NA,Classical,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,46,male,20.370038,1,80,NA,0.151055098,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.74,2.04,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,55,male,28.3866336,1,NA,NA,0.211734694,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.81,1.98,NA,NA,NA,Neural,NE,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,52,male,15.0475442,1,100,NA,0.168386428,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,1.99,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,46,male,53.8163262,1,80,NA,0.217360017,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.61,3.89,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,24,male,43.2041935,1,100,NA,0.135431748,WT,non-codel,IDHwt,NA,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,2.16,NA,NA,NA,Neural,NA,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,75,female,7.6223368,1,60,NA,0.140677769,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.44,1.98,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,52,male,9.7250504,1,80,NA,0.306089874,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.5,1.87,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,53,male,14.9161246,1,80,NA,0.356585944,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.64,2.21,NA,NA,NA,Mesenchymal,ME,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,51,female,14.8504148,1,80,NA,0.183870962,NA,non-codel,NA,NA,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.82,2.01,NA,NA,NA,Classical,CL,LGr4,NA,NA,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,45,female,91.6980259,1,NA,NA,0.223081131,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.91,2.08,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,49,female,24.7725946,1,60,NA,0.286425102,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.49,6.12,NA,NA,NA,Classical,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,40,male,18.4644538,1,100,NA,0.152609674,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,2.02,NA,NA,NA,Classical,CL,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,62,male,10.6121327,1,60,61,0.382560133,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.169925001,Expressed,WT,WT,WT,WT,0.9,1.89,741.5429,995.2589,1736.8018,Neural,NA,LGr4,IDHwt-R3,LGm6,IDHwt-K3,LGm6-GBM,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,46,male,23.4912535,1,80,NA,0.224374945,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.49,2.05,NA,NA,NA,Neural,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,38,female,27.7623905,1,NA,NA,0.351100495,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.5,4.71,NA,NA,NA,Neural,NE,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,38,female,38.7359271,1,100,NA,0.32811468,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.59,5.48,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,57,male,8.9365328,1,60,NA,0.105779699,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,2.01,NA,NA,NA,Neural,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,75,male,20.5671674,1,80,NA,0.187500633,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.41,2.05,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,53,female,127.5098669,1,80,NA,0.306672054,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.69,2.01,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,64,male,5.8153173,1,NA,NA,0.14096923,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.76,1.96,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,58,male,7.5894819,1,60,NA,0.091157962,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.9,2.17,NA,NA,NA,Mesenchymal,NA,LGr4,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,10,female,33.183449,1,80,NA,0.643113253,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,1.85,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,58,male,21.7170889,1,80,NA,0.278704666,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.49,3.99,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,66,female,15.9674814,1,80,NA,0.256797853,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.4,1.92,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,56,male,12.2220228,1,100,NA,0.180554552,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.78,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,65,female,15.8360618,1,100,NA,0.172858619,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.64,1.95,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,55,male,9.1008073,1,80,NA,0.220838059,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.48,2.04,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,61,male,14.5218658,1,100,NA,0.18379003,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,1.92,NA,NA,NA,Neural,NA,LGr4,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,75,female,3.9754429,1,60,NA,0.281655333,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,2.1,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,68,female,4.1397174,1,80,NA,0.550375789,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.77,3.86,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,NA,NA,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,62,female,22.1770575,1,80,51,0.220611869,WT,NA,NA,Unmethylated,NA,NA,NA,4.584962501,Expressed,WT,WT,WT,WT,NA,NA,1137.811,1341.873,2479.684,Proneural,PN,LGr1,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,75,female,15.6389324,1,NA,NA,0.586633002,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.91,1.96,NA,NA,NA,Neural,PN,LGr1,NA,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,47,female,25.6596769,1,80,NA,0.137387117,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.71,2.01,NA,NA,NA,Neural,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,86,male,14.7189952,1,80,NA,0.262568428,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.9,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,0.11538992,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,58,male,6.7681094,1,60,NA,0.599429317,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.81,3.21,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,47,female,59.7302082,1,60,NA,0.25883302,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.84,1.98,NA,NA,NA,Neural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,59,female,43.9927111,1,80,NA,0.683609195,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.96,1.88,NA,NA,NA,Proneural,PN,LGr1,NA,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,61,female,26.9081631,1,80,NA,0.160233933,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.94,2.04,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,76,male,15.2118187,1,80,84,0.175754301,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.77,1.99,NA,NA,NA,Neural,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,46,male,10.9406817,1,80,55,0.129701282,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.459431619,Expressed,WT,WT,WT,WT,0.88,2.02,680.6315,1524.422,2205.0534,Proneural,CL,LGr1,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,77,male,12.6819914,1,80,NA,0.206631609,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.67,1.93,NA,NA,NA,Neural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,60,male,34.8919038,1,80,63,0.17497295,WT,non-codel,IDHwt,Unmethylated,No combined CNA,Gain chr 19/20,NA,5.672425342,Expressed,WT,WT,WT,WT,0.92,1.94,244.6351,1177.3104,1421.9455,Classical,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,34,female,14.5218658,1,80,27,0.947695708,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.584962501,Expressed,WT,WT,WT,WT,0.92,3.44,615.8196,2131.5248,2747.3444,Classical,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,60,female,14.9161246,1,NA,76,0.246806056,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,0.74,1.91,1045.729,2738.576,3784.305,Neural,ME,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,56,female,3.2197802,1,80,39,0.163054098,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.169925001,Expressed,WT,WT,WT,WT,0.91,2.05,1206.29,1977.777,3184.067,Classical,CL,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NADuke,Glioblastoma multiforme,glioblastoma,G4,59,male,2.0370038,1,80,75,0.148013444,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.87,1.96,NA,NA,NA,Neural,PN,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,49,male,15.113254,1,100,NA,0.606172801,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.57,3.52,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,NA,NA,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,70,male,11.9591836,1,60,47,0.841697659,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.89,3.6,NA,NA,NA,NA,NA,NA,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,49,male,0.9527921,1,NA,22,0.102132073,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,0.22,2.06,2339.387,2518.752,4858.139,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,36,female,6.2095761,1,80,NA,0.35520517,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.68,5.96,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,NA,NA,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,50,female,23.0312849,1,80,38,0.143413771,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.9,2.01,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,6.5938,3.0463Emory University,Glioblastoma multiforme,glioblastoma,G4,69,male,2.2341332,1,60,36,0.203901133,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.321928095,Expressed,WT,WT,WT,WT,0.85,1.95,793.2571,1999.7309,2792.988,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,54,male,11.2363758,1,40,78,0.126184229,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.169925001,Expressed,WT,WT,WT,WT,0.56,2.03,1976.925,2977.316,4954.241,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,64,female,13.7662031,1,60,66,0.172084782,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.554588852,Expressed,WT,WT,WT,WT,0.93,2.03,446.5312,773.5505,1220.0818,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,65,male,3.2526351,1,40,NA,0.16729891,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.67,1.92,NA,NA,NA,Neural,NE,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,78,male,1.3470509,1,60,90,0.305402102,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.78,2,NA,NA,NA,Proneural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,69,female,5.3882036,1,60,67,0.477485331,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,NA,NA,1964.133,3176.644,5140.777,Neural,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,60,male,2.8912312,1,40,43,0.703918944,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.68,1.72,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,67,male,16.4931598,1,60,NA,0.869239921,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,1.87,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,55,male,26.3167749,1,80,NA,0.146840987,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.76,2.04,NA,NA,NA,Neural,CL,LGr4,NA,LGm4,NA,NA,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,67,male,2.0370038,1,60,NA,0.496511724,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.64,5.82,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,74,female,28.912312,1,60,48,0.669174283,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.64385619,Expressed,WT,WT,WT,WT,0.93,5.44,631.8796,184.9579,816.8375,Mesenchymal,NA,LGr4,IDHwt-R2,LGm6,IDHwt-K3,LGm6-GBM,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,60,female,15.9346265,1,60,80,0.534244575,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,3.584962501,Expressed,WT,WT,WT,WT,0.54,3.95,1359.09,2593.52,3952.609,Mesenchymal,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,4.0534,2.1149Emory University,Glioblastoma multiforme,glioblastoma,G4,66,female,19.2858263,1,60,NA,0.162172914,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.51,1.95,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,61,male,0.7885176,1,40,23,0.121256024,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.55,2.05,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,52,male,1.3799058,1,80,57,0.176134855,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.91,1.99,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,78,female,1.1170666,1,60,NA,0.272092687,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.76,2.14,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,54,male,3.7454586,1,80,NA,0.109010713,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.65,2,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,NA,NA,3.3464,3.1376Emory University,Glioblastoma multiforme,glioblastoma,G4,58,female,32.0335275,1,80,NA,0.142630301,NA,non-codel,NA,Methylated,No combined CNA,Gain chr 19/20,Mutant,NA,NA,NA,NA,NA,NA,0.79,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,4.0808,5.3583Emory University,Glioblastoma multiforme,glioblastoma,G4,57,female,58.7445612,0,80,56,0.188177934,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.68,1.97,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,39,male,23.0969947,1,80,NA,0.187310011,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,1.95,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,60,male,7.0966584,1,80,NA,0.176744651,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.74,2.08,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,NA,NA,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,69,male,1.1499215,1,60,NA,0.794209308,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,1.86,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,54,female,30.1607982,1,60,NA,0.40312755,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.95,3.03,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,NA,NA,5.9953,2.2925Emory University,Glioblastoma multiforme,glioblastoma,G4,61,male,0.9199372,1,NA,NA,0.189269284,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,1.97,NA,NA,NA,Proneural,PN,LGr1,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,23,male,40.9372054,0,80,22,0.094413818,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.8,2.04,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,54,male,6.6695447,1,80,NA,0.224230767,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.35,3.86,NA,NA,NA,G-CIMP,NE,LGr2,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,63,female,12.4191522,1,100,NA,0.123323838,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.99,NA,NA,NA,Neural,NA,LGr4,NA,LGm5,NA,NA,5.739,4.3306Emory University,Glioblastoma multiforme,glioblastoma,G4,59,male,0.985647,1,NA,NA,0.308268667,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.52,4.88,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,66,male,1.971294,1,60,NA,0.102711336,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.69,2.01,NA,NA,NA,Proneural,PN,LGr1,NA,LGm4,IDHwt-K1,Classic-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,31,male,17.7745009,1,80,NA,0.229210431,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.98,1.94,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,58,female,17.8402107,1,80,47,0.828086067,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,2.321928095,Expressed,WT,WT,WT,WT,0.64,2.55,1453.487,3032.773,4486.26,Mesenchymal,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,6.3528,2.9666Emory University,Glioblastoma multiforme,glioblastoma,G4,70,male,7.6223368,1,80,52,0.281381991,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.807354922,Expressed,WT,WT,WT,WT,0.88,2.17,332.504,767.7075,1100.2115,Proneural,PN,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,51,male,5.8810271,1,100,NA,0.142255781,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,2.06,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,57,male,7.1623682,0,60,53,0.200083194,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.7,2.03,1837.06,2540.047,4377.107,Neural,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,52,female,17.4788068,1,60,71,0.213501283,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,1,Not expressed,WT,WT,WT,WT,0.81,2.09,1237.136,2443.457,3680.592,Neural,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,6.1813,4.6279Emory University,Glioblastoma multiforme,glioblastoma,G4,44,female,7.9508858,0,80,NA,0.145267421,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.97,2.05,NA,NA,NA,Neural,CL,LGr4,NA,LGm5,NA,NA,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,74,male,0.3942588,1,NA,47,0.219657182,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,Neural,NE,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,38,female,3.7783135,0,80,NA,0.714792357,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.92,5.34,NA,NA,NA,Proneural,PN,LGr1,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NAEmory University,Glioblastoma multiforme,glioblastoma,G4,40,male,3.4169096,0,60,31,0.162790795,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.97,1.96,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAMayo Clinic - Rochester,Glioblastoma multiforme,glioblastoma,G4,65,male,13.7662031,1,80,71,0.26642733,WT,non-codel,IDHwt,NA,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,7.129283017,Expressed,WT,WT,WT,WT,0.92,1.94,274.4584,929.8476,1204.3061,Classical,CL,LGr4,IDHwt-R1,NA,NA,NA,NA,NAMayo Clinic - Rochester,Glioblastoma multiforme,glioblastoma,G4,21,male,50.4979813,1,NA,21,0.099363182,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,WT,1,Not expressed,Mutant,WT,WT,WT,0.59,1.92,1522.504,2096.473,3618.977,Proneural,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,6.2051,12.5638Mayo Clinic - Rochester,Glioblastoma multiforme,glioblastoma,G4,55,male,19.0886969,0,80,NA,0.111599767,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.69,2.01,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAMayo Clinic - Rochester,Glioblastoma multiforme,glioblastoma,G4,36,female,53.1592282,0,80,NA,0.886113503,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.86,2.71,NA,NA,NA,Proneural,NE,LGr1,NA,LGm6,NA,NA,NA,NAMayo Clinic - Rochester,Glioblastoma multiforme,glioblastoma,G4,65,male,13.2733796,1,60,NA,0.442605303,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.47,5.56,NA,NA,NA,Proneural,NE,LGr1,NA,LGm5,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,85,male,3.9097331,1,NA,58,0.333309852,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.64,3.72,1027.118,2526.206,3553.324,Proneural,NA,LGr4,IDHwt-R4,LGm5,IDHwt-K1,Classic-like,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,57,male,17.5773715,1,NA,NA,0.219372257,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,2.04,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,54,male,26.0539357,0,NA,NA,0.104026295,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.86,2,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm2,IDHmut-K2,G-CIMP-high,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,52,female,16.3617402,1,NA,NA,0.817702328,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,1,3.48,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm1,IDHmut-K1,G-CIMP-low,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,65,male,4.3039919,NA,NA,58,0.192682318,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.88,1.91,NA,NA,NA,Classical,NA,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,49,female,29.0108767,1,NA,72,0.284026483,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.49,3.55,2549.004,3367.09,5916.095,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,66,female,4.5668311,1,NA,NA,0.174285204,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.91,1.93,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,64,0.195310348,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.67,2.02,NA,NA,NA,NA,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,48,male,10.2835837,1,NA,NA,0.157663857,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.71,2.03,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,55,male,13.9961874,1,NA,NA,0.124122437,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,1.93,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,70,female,9.1336622,1,NA,NA,0.138428554,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.71,1.92,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,57,female,21.2242654,1,NA,NA,0.146229777,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,2.03,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,NA,NAToronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,72,male,13.9633325,1,NA,NA,0.174826338,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,1.96,NA,NA,NA,Neural,CL,LGr4,NA,LGm4,NA,NA,5.9884,1.2377Toronto Western Hospital,Glioblastoma multiforme,glioblastoma,G4,36,female,6.4067055,0,NA,NA,0.046893359,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.74,2.03,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm2,IDHmut-K2,G-CIMP-high,8.8696,13.9348Case Western,Glioblastoma multiforme,glioblastoma,G4,71,male,11.7620542,0,NA,NA,0.212572681,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.52,2.11,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,48,female,21.8813634,1,NA,NA,0.172372959,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.74,2.08,NA,NA,NA,Proneural,PN,LGr1,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,83,female,8.6079838,0,60,NA,0.203643836,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,1.99,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,77,female,0.657098,1,40,NA,0.181218061,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.77,1.94,NA,NA,NA,Mesenchymal,NE,LGr4,NA,LGm5,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,61,male,14.2590266,1,NA,NA,0.145376738,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.72,1.97,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,70,male,3.3840547,0,60,NA,0.078224075,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.93,1.93,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,69,male,10.7435523,1,NA,NA,0.133807492,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,51,male,9.0679524,1,80,NA,0.164006767,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.89,2.03,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,81,male,5.9467369,0,60,NA,0.181533688,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.82,2.06,NA,NA,NA,Proneural,PN,LGr1,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,58,male,12.9448306,1,NA,NA,0.643790562,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.65,3.49,NA,NA,NA,Mesenchymal,NA,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,51,male,4.6325409,1,80,NA,0.190433981,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,NA,NA,NA,NA,NA,NA,0.37,1.91,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,5.1887,5.5038Case Western,Glioblastoma multiforme,glioblastoma,G4,63,female,25.3639828,1,60,116,0.631137131,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,8.204571144,Expressed,WT,WT,WT,WT,0.79,3.73,206.3472,556.1058,762.453,Proneural,PN,LGr1,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,72,female,3.6468939,1,60,NA,0.585175401,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,1,3.76,NA,NA,NA,Proneural,PN,LGr1,NA,LGm4,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,64,female,7.1623682,0,40,NA,0.417559845,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.87,2.07,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,48,male,12.6491365,1,80,NA,0.723473074,NA,non-codel,NA,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,0,Not expressed,NA,NA,NA,WT,0.86,1.23,973.8069,2183.9733,3157.7801,Mesenchymal,ME,LGr4,NA,LGm4,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,39,male,3.6797488,1,60,NA,0.03959398,Mutant,NA,NA,Methylated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,G-CIMP,NE,LGr3,NA,LGm2,IDHmut-K2,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,69,female,3.2526351,1,60,NA,0.106846095,WT,non-codel,IDHwt,Methylated,No combined CNA,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.9,1.98,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,56,male,5.0596546,1,60,80,0.143401591,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,82,female,0.1314196,0,NA,NA,0.177661548,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.96,2.03,NA,NA,NA,Neural,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,55,female,9.6593406,0,40,50,0.208152425,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,6.303780748,Expressed,WT,WT,WT,WT,0.89,1.94,1006.7912,777.7432,1784.5344,Classical,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,70,male,4.8625252,1,40,69,0.175117551,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,Mutant,2.807354922,Expressed,WT,WT,WT,WT,0.68,1.96,1374.362,1470.596,2844.957,Neural,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,6.51,2.5571Case Western,Glioblastoma multiforme,glioblastoma,G4,83,male,1.0842117,1,NA,NA,0.105118372,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.92,1.91,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,65,male,7.5237721,0,80,84,0.288493697,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.73,1.86,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,51,male,0.1642745,1,NA,34,0.10726244,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.392317423,Expressed,WT,WT,WT,WT,1,2.01,210.7507,198.6668,409.4175,Proneural,CL,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,6.3588,2.4228Case Western,Glioblastoma multiforme,glioblastoma,G4,76,female,4.0740076,1,NA,51,0.23567947,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,4.95419631,Expressed,WT,WT,WT,WT,0.65,1.94,900.0944,1387.5631,2287.6575,Classical,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,60,male,24.2140613,1,NA,76,0.758477282,Mutant,non-codel,IDHmut-non-codel,Unmethylated,No combined CNA,No chr 19/20 gain,WT,0,Not expressed,Mutant,WT,WT,WT,0.59,3.52,1229.383,2200.493,3429.877,G-CIMP,NA,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,6.6709,16.8716Case Western,Glioblastoma multiforme,glioblastoma,G4,74,female,6.9980937,1,60,79,0.144038405,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.86,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,36,male,7.0309486,0,NA,NA,0.453824885,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2,Expressed,NA,NA,NA,WT,0.48,3.13,1968.098,3006.072,4974.17,NA,ME,LGr4,NA,LGm5,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,68,female,4.5011213,0,80,60,0.162918165,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,47,female,6.6366898,1,40,24,0.313517313,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.57,1.84,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,52,female,11.2692307,0,100,57,0.159672104,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.82,2.04,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,76,female,8.0165956,1,80,80,0.096855987,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.93,1.98,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,62,male,18.8915675,1,60,45,0.162568673,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.69,1.94,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,58,male,4.7311056,1,NA,49,0.179422605,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.54,2,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,72,female,7.9508858,0,60,87,0.140281359,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.79,2.02,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,83,male,1.7741646,1,NA,59,0.18395126,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.38,1.97,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,53,female,6.5052702,0,80,NA,0.219465044,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,3.83,NA,NA,NA,Proneural,PN,LGr1,NA,LGm6,NA,NA,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,56,male,5.3882036,0,80,42,0.146258946,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.71,2.03,NA,NA,NA,Classical,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,77,female,5.2896389,0,80,93,0.146812241,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.91,2.01,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,56,male,5.4210585,0,80,41,0.84795021,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,7.851749041,Expressed,WT,WT,WT,WT,0.97,1.85,-264.34754,203.17831,-61.16922,Proneural,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,5.1261,5.3965Case Western,Glioblastoma multiforme,glioblastoma,G4,39,male,6.7681094,0,NA,30,0.179032029,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,68,male,3.9754429,1,NA,28,0.624275072,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACase Western,Glioblastoma multiforme,glioblastoma,G4,40,male,16.5588696,0,100,45,0.231558961,Mutant,non-codel,IDHmut-non-codel,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm3,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,36,male,10.0207445,0,100,NA,0.15488567,NA,non-codel,NA,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.46,2,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,NA,NA,6.3102,1.523University of Florida,Glioblastoma multiforme,glioblastoma,G4,63,male,13.8647678,1,NA,42,0.548296949,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.62,3.46,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,48,male,9.7250504,0,80,NA,0.284121832,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.77,2.11,NA,NA,NA,Classical,CL,LGr4,NA,LGm6,NA,NA,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,43,male,31.3107197,0,80,39,0.076337064,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.79,1.99,670.852,1029.976,1700.828,G-CIMP,NA,LGr3,IDHmut-R3,LGm2,IDHmut-K2,G-CIMP-high,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,60,female,7.1295133,0,60,NA,0.123102689,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.9,2.04,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,68,male,9.3636465,1,60,NA,0.13032592,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.84,2.03,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,74,male,9.3965014,0,60,45,0.170621352,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.523561956,Expressed,WT,WT,WT,WT,0.84,1.94,990.3629,1668.716,2659.0789,Classical,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,3.8446,4.5576University of Florida,Glioblastoma multiforme,glioblastoma,G4,59,male,14.8504148,0,80,30,0.864103045,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.88,1.77,845.9668,614.2782,1460.2451,G-CIMP,NA,LGr3,IDHwt-R3,LGm1,IDHwt-K3,LGm6-GBM,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,74,male,5.4867683,0,60,54,0.080263834,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,4.95419631,Expressed,WT,WT,WT,WT,0.92,1.93,676.9619,1195.3633,1872.3252,Proneural,NA,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,72,female,8.870823,1,NA,67,0.107627899,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.64385619,Expressed,WT,WT,WT,WT,0.82,2,1912.711,1919.669,3832.379,Proneural,ME,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,3.8834,2.9753University of Florida,Glioblastoma multiforme,glioblastoma,G4,78,female,1.2156313,0,NA,48,0.279971279,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.321928095,Expressed,WT,WT,WT,WT,0.83,1.99,1263.911,2503.971,3767.882,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,65,female,1.5770352,0,60,49,0.129631816,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.285402219,Expressed,WT,WT,WT,WT,0.8,2.01,1257.282,1818.943,3076.225,Mesenchymal,CL,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,57,male,7.9180309,0,80,36,0.273633015,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.56,2.04,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,65,female,2.3326979,0,80,85,0.121408754,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.5,2.07,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAUniversity of Florida,Glioblastoma multiforme,glioblastoma,G4,47,male,8.542274,0,NA,37,0.119778643,WT,non-codel,IDHwt,Methylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,57,male,5.0596546,1,80,41,0.235925875,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.64,1.9,1945.588,2243.124,4188.712,Proneural,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,66,male,16.5917245,1,80,53,0.097699129,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,4.392317423,Expressed,WT,WT,WT,WT,0.68,2.07,1542.637,2692.716,4235.353,Neural,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,5.7031,1.8876"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,59,female,9.85647,1,100,34,0.237215055,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.087462841,Expressed,WT,WT,WT,WT,0.57,1.91,1659.624,2978.704,4638.328,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,67,female,24.2140613,1,80,61,0.186490029,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.93,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,56,male,40.5100917,1,80,41,0.503949341,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,1,Not expressed,WT,WT,WT,WT,0.76,1.91,1005.614,2487.626,3493.239,Neural,NA,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,53,female,21.2899752,1,80,68,0.19472078,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,10.509775,Expressed,WT,WT,WT,WT,0.87,2,606.4254,685.2033,1291.6287,Classical,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,33,female,30.0293786,1,80,45,0.068224021,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.7,1.94,NA,NA,NA,Proneural,NE,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,36,male,14.0290423,1,80,40,0.10264776,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,5.392317423,Expressed,WT,WT,WT,WT,0.82,1.96,1107.842,1891.649,2999.49,Classical,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,59,female,11.499215,1,80,81,0.202989385,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.72,4.29,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,52,male,24.7397397,1,80,46,0.127730234,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.66,2.03,NA,NA,NA,Neural,NE,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,48,male,10.3821484,0,80,39,0.239724368,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.7,1.91,1413.313,2927.738,4341.051,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,34,male,10.3821484,0,80,45,0.358065325,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,Mutant,WT,WT,WT,0.91,1.96,711.4736,501.6545,1213.1281,G-CIMP,PN,LGr3,IDHmut-R3,LGm1,IDHmut-K1,G-CIMP-low,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,63,male,16.0660461,1,80,50,0.127960297,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,5.700439718,Expressed,WT,WT,WT,WT,0.92,2.03,328.8182,1023.2712,1352.0894,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,4.8883,2.4021"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,56,male,7.5894819,1,80,50,0.374413371,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.087462841,Expressed,WT,WT,WT,WT,0.8,1.86,1769.693,2358.826,4128.518,Mesenchymal,ME,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,79,female,2.8583763,1,40,46,0.181626771,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.321928095,Expressed,WT,WT,WT,WT,0.86,2.09,651.7963,2397.8721,3049.6684,Neural,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,81,male,14.3904462,1,80,52,0.124823249,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.36,1.94,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NA"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Glioblastoma multiforme,glioblastoma,G4,62,male,15.770352,1,80,50,0.113233665,WT,non-codel,IDHwt,Methylated,No combined CNA,Gain chr 19/20,Mutant,4.95419631,Expressed,WT,WT,WT,WT,0.76,2.01,1497.14,711.6582,2208.7982,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,4.5671,7.6945Cedars Sinai,Glioblastoma multiforme,glioblastoma,G4,76,male,11.3349405,0,60,NA,0.001924079,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,77,female,0.1971294,0,80,NA,0.192401882,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,2.13,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,44,male,2.5298273,1,NA,41,0.109159449,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,5.554588852,Expressed,WT,WT,WT,WT,0.8,1.96,850.3133,2574.1483,3424.4616,Classical,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,73,male,9.199372,0,80,NA,0.150582375,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.9,2.04,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,40,female,8.3451446,0,60,NA,0.43127603,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.7,1.82,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,61,female,7.6223368,0,80,NA,0.184341823,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.39,2.06,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,42,female,8.4765642,0,80,NA,0.196510266,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.53,1.95,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,53,male,1.2156313,0,NA,45,0.12714407,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.727920455,Expressed,WT,WT,WT,WT,0.62,2,2509.61,2893.989,5403.599,Mesenchymal,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,52,female,1.5441803,1,60,NA,0.120466312,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,1.98,NA,NA,NA,Classical,NA,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,78,male,2.8255214,0,80,NA,0.139873021,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.78,1.89,NA,NA,NA,G-CIMP,NE,LGr3,NA,LGm3,NA,NA,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,71,male,0.1314196,0,80,NA,0.149217497,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.74,2.02,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,48,male,4.6982507,0,NA,NA,0.232494766,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,59,male,14.5218658,0,NA,28,NA,WT,NA,NA,Unmethylated,NA,NA,NA,0,Not expressed,WT,WT,WT,WT,NA,NA,498.3427,1797.3998,2295.7425,NA,CL,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,44,0.157789257,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.33,1.94,NA,NA,NA,NA,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,65,male,0.657098,0,20,53,0.178363075,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.51,1.98,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,63,female,6.7352545,0,80,NA,0.613391597,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,NA,NA,NA,NA,0.5,3.37,NA,NA,NA,Neural,NE,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,77,female,4.7639605,0,80,55,0.636623197,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.584962501,Expressed,WT,WT,WT,WT,0.74,4.18,768.1678,1860.0082,2628.176,Mesenchymal,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,20,0.198652607,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.3,2.05,1620.1882,929.2826,2549.4708,NA,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,LGm6-GBM,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,37,male,11.2692307,1,90,NA,NA,NA,NA,NA,Unmethylated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm6,NA,NA,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,69,female,7.2937878,0,80,65,0.155055459,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.32,2.02,2566.75,3161.917,5728.667,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,45,male,5.256784,0,60,49,0.412023486,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,4.64385619,Expressed,WT,WT,WT,WT,0.88,1.93,996.8528,1126.6615,2123.5143,Classical,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,72,male,14.9161246,1,80,41,0.325648469,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.781359714,Expressed,WT,WT,WT,WT,0.89,1.93,888.8619,1778.3407,2667.2026,Neural,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,71,male,11.2692307,1,70,49,0.229607704,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.584962501,Expressed,WT,WT,WT,WT,0.75,2.03,1434.455,1607.705,3042.159,Mesenchymal,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,52,male,15.5732226,0,70,61,0.118701325,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,6.129283017,Expressed,WT,WT,WT,WT,0.87,2.02,1280.793,1812.491,3093.284,Mesenchymal,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,66,female,2.5298273,0,NA,92,0.224077869,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,7.055282436,Expressed,WT,WT,WT,WT,0.92,1.97,1015.426,1188.05,2203.476,Mesenchymal,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,42,male,11.7620542,0,100,45,0.129703418,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.47,1.99,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,72,male,9.7907602,0,80,49,0.24009534,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.49,1.87,2492.07,3735.564,6227.634,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,53,male,14.1933168,0,70,34,0.161778528,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.76,2.04,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,62,female,11.0063915,1,90,30,0.446407974,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,0.77,1.91,2183.34,2102.46,4285.8,Mesenchymal,PN,LGr3,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,52,male,13.6347835,0,80,46,0.437866174,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.906890596,Expressed,WT,WT,WT,WT,NA,NA,1428.714,1684.237,3112.95,Mesenchymal,ME,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,63,male,5.1582193,1,NA,21,0.700762806,WT,non-codel,IDHwt,Unmethylated,No combined CNA,Gain chr 19/20,NA,0,Not expressed,WT,WT,WT,WT,0.6,2.68,3155.509,3251.506,6407.015,Mesenchymal,ME,LGr4,IDHwt-R2,LGm6,IDHwt-K3,LGm6-GBM,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,47,female,8.5094191,0,70,44,0.291372846,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.74,2.09,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,67,male,10.4807131,0,90,35,0.626100169,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.89,1.83,440.0687,1904.3113,2344.3799,Classical,NA,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACedars Sinai,Glioblastoma multiforme,glioblastoma,G4,60,male,5.4210585,1,NA,57,0.16587896,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.76,2.06,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,59,male,15.3760932,1,NA,77,0.260215363,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,Mutant,5,Expressed,WT,WT,WT,WT,0.87,2.06,710.9047,1319.4283,2030.3331,Classical,CL,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,5.0068,4.9429St. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,21,male,21.0599909,1,NA,NA,0.54739289,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.88,1.86,NA,NA,NA,Proneural,NA,LGr1,NA,LGm6,NA,NA,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,65,male,0.4928235,1,60,NA,0.330457885,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.85,2.1,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,63,female,0.0985647,0,NA,68,0.161754455,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.53,1.99,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,57,male,15.8360618,1,NA,NA,0.351036234,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.99,1.99,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,NA,NA,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,69,female,19.4829557,1,NA,78,0.153694168,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.52,4.15,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,72,male,1.1827764,1,NA,6,1.97E-05,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,1.584962501,Not expressed,WT,WT,WT,WT,0.18,1.86,2336.03,2706.402,5042.433,Neural,NE,LGr2,IDHwt-R4,LGm6,IDHwt-K3,LGm6-GBM,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,76,female,4.6653958,1,80,77,0.131541288,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.58,2.02,2157.694,2756.071,4913.765,Neural,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,68,male,12.6819914,1,20,44,0.16001396,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.53,2.1,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,49,female,14.8504148,1,NA,NA,0.282873113,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.98,4.01,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,NA,NA,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,60,male,16.9202735,1,NA,43,0.116688222,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.82,1.97,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,63,male,12.2220228,1,NA,63,0.199553403,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.58,1.92,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,58,female,20.7642968,1,NA,56,0.166463047,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.59,1.94,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,59,female,15.0146893,1,NA,65,0.295488143,WT,non-codel,IDHwt,Unmethylated,No combined CNA,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.84,2.18,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,NA,0.942848846,WT,NA,NA,Unmethylated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ME,LGr4,NA,LGm6,IDHwt-K3,LGm6-GBM,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,62,male,15.9346265,1,80,38,0.560052679,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,5.426264755,Expressed,WT,WT,WT,WT,0.84,1.87,1612.906,2222.434,3835.339,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,48,female,7.3594976,1,NA,NA,0.1457772,NA,non-codel,NA,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,NA,NA,NA,WT,0.82,2.05,746.8388,1791.5946,2538.4334,Mesenchymal,ME,LGr4,NA,LGm5,NA,NA,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,80,male,8.8379681,1,NA,90,0.269615413,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,3.169925001,Expressed,WT,WT,WT,WT,0.59,3.51,1538.988,3118.2,4657.188,Mesenchymal,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,82,male,8.870823,0,NA,50,0.757587263,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,5.169925001,Expressed,WT,WT,WT,WT,0.89,1.86,894.6539,821.6305,1716.2844,Proneural,NA,LGr1,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,67,male,7.3594976,0,NA,54,0.153019616,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,5.491853096,Expressed,WT,WT,WT,WT,0.83,1.99,2079.385,2505.542,4584.927,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,25,male,13.14196,0,NA,27,0.163563174,Mutant,non-codel,IDHmut-non-codel,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.91,1.96,NA,NA,NA,G-CIMP,PN,LGr3,NA,LGm3,IDHmut-K2,G-CIMP-high,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,40,male,11.1049562,0,NA,22,0.769112854,WT,NA,NA,Methylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,73,male,3.7126037,1,NA,74,0.758865421,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.77,6.04,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,56,male,12.5834267,1,NA,51,0.216095763,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.64,2.04,NA,NA,NA,Neural,NE,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,47,female,11.7291993,0,NA,52,0.120654794,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.69,1.88,2592.759,3118.389,5711.147,Mesenchymal,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,73,male,10.842117,1,NA,47,0.258812095,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.7,3.61,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NASt. Joseph's Hospital (AZ),Glioblastoma multiforme,glioblastoma,G4,66,male,5.4210585,0,NA,69,0.305337178,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,5.426264755,Expressed,WT,WT,WT,WT,0.58,4.46,1385.699,2566.321,3952.02,Proneural,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,89,male,0.8542274,1,60,52,0.192347005,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,5.857980995,Expressed,WT,WT,WT,WT,0.78,2.01,857.0766,889.7878,1746.8644,Proneural,PN,LGr1,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,67,male,13.3390894,1,NA,49,0.22880921,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,6.14974712,Expressed,WT,WT,WT,WT,0.84,1.96,1428.555,1946.072,3374.627,Classical,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,59,male,8.9365328,0,60,43,0.367492742,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.66,3.16,NA,NA,NA,Proneural,NE,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,75,male,9.527921,1,60,59,0.326128977,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.92,1.95,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,88,male,0.985647,1,NA,61,0.233587254,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.86,1.91,NA,NA,NA,Neural,CL,LGr4,NA,LGm5,IDHwt-K1,Classic-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,81,female,4.4354115,1,NA,71,0.166749127,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.67,2.03,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,48,male,6.0453016,0,NA,32,0.478910688,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,3.700439718,Expressed,WT,WT,WT,WT,0.77,1.83,2330.606,2572.326,4902.932,Mesenchymal,ME,LGr4,IDHwt-R3,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,63,female,0.1971294,1,NA,29,0.298685003,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,0,Not expressed,WT,WT,WT,WT,0.51,1.8,2268.464,2339.056,4607.52,Mesenchymal,ME,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NAChristiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,59,female,11.5320699,0,NA,91,0.255302657,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,Mutant,6.392317423,Expressed,WT,WT,WT,WT,0.96,2.03,541.8648,330.7782,872.6431,Proneural,PN,LGr1,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,5.1076,5.2246Christiana Healthcare,Glioblastoma multiforme,glioblastoma,G4,73,female,7.7537564,0,NA,49,0.147858453,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.68,2.01,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAUniversity of Miami,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,68,0.798434733,WT,non-codel,IDHwt,Methylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAUniversity of Miami,Glioblastoma multiforme,glioblastoma,G4,69,male,4.1397174,0,NA,48,0.264916109,WT,non-codel,IDHwt,Methylated,NA,NA,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAUniversity of Miami,Glioblastoma multiforme,glioblastoma,G4,54,female,14.7518501,0,70,49,0.168309792,WT,non-codel,IDHwt,Methylated,NA,NA,NA,NA,NA,Mutant,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NASwedish Neurosciences,Glioblastoma multiforme,glioblastoma,G4,67,male,3.4497645,1,100,45,0.20663296,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.86,1.91,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASwedish Neurosciences,Glioblastoma multiforme,glioblastoma,G4,73,female,17.5445166,0,90,81,0.191185046,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,Mutant,WT,WT,NA,0.64,1.96,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASwedish Neurosciences,Glioblastoma multiforme,glioblastoma,G4,51,male,4.3368468,0,90,39,0.18723733,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.64,2.12,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASwedish Neurosciences,Glioblastoma multiforme,glioblastoma,G4,58,male,14.3247364,0,100,64,0.127076861,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.71,2.02,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K1,Classic-like,NA,NASwedish Neurosciences,Glioblastoma multiforme,glioblastoma,G4,77,male,8.213725,0,100,NA,0.16375622,NA,non-codel,NA,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,NA,NA,NA,NA,0.89,1.99,NA,NA,NA,NA,NA,NA,NA,LGm4,NA,NA,NA,NASwedish Neurosciences,Glioblastoma multiforme,glioblastoma,G4,55,female,7.4909172,0,80,35,0.20040733,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.53,4.13,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,76,male,4.7968154,1,100,67,0.262735246,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,6.321928095,Expressed,WT,WT,WT,WT,0.94,1.92,556.7223,837.1389,1393.8612,Proneural,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,68,male,4.5339762,1,80,59,0.115562064,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4,Expressed,WT,WT,WT,WT,0.79,1.99,391.5933,1252.8291,1644.4224,Classical,CL,LGr4,IDHwt-R4,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,58,male,17.5773715,1,80,48,NA,WT,NA,NA,Unmethylated,NA,NA,NA,4.459431619,Expressed,WT,WT,WT,WT,NA,NA,2074.908,2108.75,4183.658,Neural,CL,LGr4,IDHwt-R3,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,85,female,3.0883606,1,80,68,0.178277558,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,4.459431619,Expressed,WT,WT,Mutant,WT,0.42,3.9,1451.334,2201.337,3652.671,Classical,ME,LGr4,IDHwt-R2,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,76,female,3.6468939,1,80,67,0.790365314,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,2.807354922,Expressed,WT,WT,WT,WT,0.8,3.48,810.7105,1412.2666,2222.977,Neural,NA,LGr4,IDHwt-R2,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,70,female,9.1665171,1,80,43,0.154705979,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,6.599912842,Expressed,WT,WT,WT,WT,0.93,1.95,325.0676,862.0196,1187.0872,Classical,CL,LGr4,IDHwt-R1,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,50,female,47.9024442,1,80,60,0.195053845,WT,NA,NA,Methylated,NA,NA,NA,5.087462841,Expressed,WT,WT,WT,WT,NA,NA,658.2789,1520.8708,2179.1498,Proneural,CL,LGr4,IDHwt-R1,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,66,female,2.5298273,1,80,51,0.583439751,WT,non-codel,IDHwt,Methylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.83,3.41,NA,NA,NA,Proneural,PN,LGr1,NA,LGm6,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,52,female,10.7764072,0,80,42,0.219488203,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,Mutant,WT,NA,0.92,1.96,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,57,male,16.6902892,1,80,59,0.152956177,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.89,1.95,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,74,male,3.28549,1,80,53,0.107514413,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.53,2,NA,NA,NA,Proneural,PN,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,78,male,2.6941018,1,60,44,0.172276123,WT,non-codel,IDHwt,Unmethylated,No combined CNA,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.43,1.83,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,57,male,11.3677954,1,80,54,0.267032233,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.79,2.02,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,63,male,17.0516931,1,80,45,0.192024339,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.57,1.92,NA,NA,NA,Mesenchymal,ME,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,93,0.377731985,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.91,2.07,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,64,female,8.3451446,1,80,58,0.908221956,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.88,1.85,NA,NA,NA,Proneural,PN,LGr1,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,60,male,20.9614262,1,80,67,0.454639354,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.93,1.89,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,66,male,4.8296703,1,60,100,0.124082893,WT,non-codel,IDHwt,Methylated,No combined CNA,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.84,2.04,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,74,male,5.0267997,1,80,58,0.152291556,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.82,2.01,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,79,0.353392328,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.75,4.06,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,54,male,0.2299843,0,60,52,0.150768666,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.81,2.03,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,58,male,9.2650818,0,80,40,0.121174298,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.6,2.05,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,44,female,7.7209015,0,80,52,0.122387586,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.58,2.04,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAThomas Jefferson University,Glioblastoma multiforme,glioblastoma,G4,49,female,7.7866113,0,80,54,0.151111372,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,0.71,2.01,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACHI-Penrose Colorado,Glioblastoma multiforme,glioblastoma,G4,64,male,1.6098901,1,40,45,0.141411011,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.9,1.97,NA,NA,NA,Classical,CL,LGr4,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NACHI-Penrose Colorado,Glioblastoma multiforme,glioblastoma,G4,33,male,17.7087911,0,NA,28,0.175311447,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.79,2,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NAInternational Genomics Consortium,Glioblastoma multiforme,glioblastoma,G4,50,female,0.0657098,0,NA,58,0.14959944,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,0.86,2,NA,NA,NA,Classical,CL,LGr4,NA,LGm4,IDHwt-K1,Classic-like,NA,NAUniversity of North Carolina,Glioblastoma multiforme,glioblastoma,G4,68,male,5.913882,1,NA,40,0.675850433,WT,non-codel,IDHwt,Methylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital AZ,Glioblastoma multiforme,glioblastoma,G4,72,female,6.2752859,1,NA,48,0.142157229,WT,non-codel,IDHwt,Methylated,No combined CNA,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital AZ,Glioblastoma multiforme,NA,NA,NA,NA,NA,NA,NA,38,0.177621524,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,No chr 19/20 gain,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm5,IDHwt-K2,Mesenchymal-like,NA,NASt. Joseph's Hospital AZ,Glioblastoma multiforme,glioblastoma,G4,55,male,20.5343125,1,NA,52,0.154589771,WT,non-codel,IDHwt,Unmethylated,Gain chr 7 & loss chr 10,Gain chr 19/20,NA,NA,NA,WT,WT,WT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,LGm4,IDHwt-K1,Classic-like,NA,NA